View Inc. - Ordinary Shares (VIEW) 10-Q 28 Jun 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	Jun. 23, 2022
Entity Listings [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-39470
Entity Registrant Name	VIEW, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-3235065
Entity Address, Address Line One	195 South Milpitas Blvd
Entity Address, City or Town	Milpitas
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95035
City Area Code	408
Local Phone Number	263-9200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		219,227,971
Amendment Flag	false
Entity Central Index Key	0001811856
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Class A common stock, par value, $0.0001 per share
Entity Listings [Line Items]
Title of 12(b) Security	Class A common stock, par value, $0.0001 per share
Trading Symbol	VIEW
Security Exchange Name	NASDAQ
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
Entity Listings [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
Trading Symbol	VIEWW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 200,532	$ 281,081
Accounts receivable, net of allowances	29,940	30,605
Inventories	13,807	10,267
Prepaid expenses and other current assets	21,059	21,579
Total current assets	265,338	343,532
Property and equipment, net	265,736	268,401
Restricted cash	16,466	16,462
Right-of-use assets	20,515	21,178
Other assets	26,087	29,493
Total assets	594,142	679,066
Current liabilities:
Accounts payable	17,361	24,186
Accrued expenses and other current liabilities	59,762	59,456
Accrued compensation	10,209	9,508
Deferred revenue	8,998	11,460
Total current liabilities	96,330	104,610
Debt, non-current	13,960	13,960
Sponsor earn-out liability	3,331	7,624
Lease liabilities	22,187	22,997
Other liabilities	43,900	50,537
Total liabilities	179,708	199,728
Commitments and contingencies
Stockholders’ equity (deficit):
Common stock, $0.0001 par value; 600,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 219,222,346 and 219,195,971 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	22	22
Additional paid-in capital	2,754,115	2,736,647
Accumulated deficit	(2,339,703)	(2,257,331)
Total stockholders’ equity (deficit)	414,434	479,338
Total liabilities and stockholders’ equity (deficit)	$ 594,142	$ 679,066

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (unaudited) (Parentheticals) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Mar. 12, 2021	Mar. 08, 2021	Mar. 07, 2021
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000	600,000,000
Common stock, shares issued (in shares)	219,222,346	219,195,971
Common stock, share outstanding (in shares)	219,222,346	219,195,971		217,076,712	76,565,107

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue	$ 17,012	$ 9,769
Costs and expenses:
Cost of revenue	40,562	36,179
Research and development	19,695	16,570
Selling, general, and administrative	42,959	21,700
Total costs and expenses	103,216	74,449
Loss from operations	(86,204)	(64,680)
Interest and other expense (income), net
Interest expense, net	197	5,303
Other expense, net	328	1,442
Gain on fair value change, net	(4,381)	(7,413)
Loss on extinguishment of debt	0	10,018
Interest and other expense (income), net	(3,856)	9,350
Loss before provision of income taxes	(82,348)	(74,030)
Provision for income taxes	24	5
Net and comprehensive loss	(82,372)	(74,035)
Net and comprehensive loss	$ (82,372)	$ (74,035)
Net loss per share, basic (in shares)	$ (0.38)	$ (1.33)
Net loss per share, diluted (in shares)	$ (0.38)	$ (1.33)
Weighted-average shares used in calculation of net loss per share, basic (in dollars per share)	214,232,210	55,500,398
Weighted-average shares used in calculation of net loss per share, diluted (in dollars per share)	214,232,210	55,500,398

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Previously Reported	Retroactive application of reverse recapitalization (Note 2)	Common Stock	Common Stock Previously Reported	Common Stock Retroactive application of reverse recapitalization (Note 2)	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Additional Paid-In Capital Retroactive application of reverse recapitalization (Note 2)	Accumulated Deficit	Accumulated Deficit Previously Reported
Beginning balance (in shares) at Dec. 31, 2020	121,431	5,222,852	(5,101,421)
Beginning balance at Dec. 31, 2020	$ 1,812,678	$ 1,812,678
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization (in shares)	(121,431)
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization	$ (1,812,678)
Ending balance (in shares) at Mar. 31, 2021	0
Ending balance at Mar. 31, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020				1,709	73,483	(71,774)
Beginning balance at Dec. 31, 2020	(1,824,564)	$ (1,824,564)	$ 0	$ 0	$ 7	$ (7)	$ 89,789	$ 89,782	$ 7	$ (1,914,353)	$ (1,914,353)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization (in shares)				121,431
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization	1,812,678			$ 12			1,812,666
Reverse recapitalization transaction, net of fees (in shares)				93,865
Reverse recapitalization transaction, net of fees	745,751			$ 10			745,741
Conversion of redeemable convertible preferred stock warrants to common stock warrants in connection with reverse recapitalization	7,267						7,267
Issuance of common stock upon exercise of stock options (in shares)				72
Issuance of common stock upon exercise of stock options	382						382
Stock-based compensation	10,463						10,463
Net loss	(74,035)									(74,035)
Ending balance (in shares) at Mar. 31, 2021				217,077
Ending balance at Mar. 31, 2021	677,942			$ 22			2,666,308			(1,988,388)
Beginning balance (in shares) at Dec. 31, 2021				219,196
Beginning balance at Dec. 31, 2021	$ 479,338			$ 22			2,736,647			(2,257,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)				26
Issuance of common stock upon exercise of stock options (in shares)	0
Stock-based compensation	$ 17,468						17,468
Net loss	(82,372)									(82,372)
Ending balance (in shares) at Mar. 31, 2022				219,222
Ending balance at Mar. 31, 2022	$ 414,434			$ 22			$ 2,754,115			$ (2,339,703)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (82,372)	$ (74,035)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,951	7,029
Loss on extinguishment of debt	0	10,018
Gain on fair value change, net	(4,381)	(7,413)
Stock-based compensation	17,468	10,463
Other	329	488
Changes in operating assets and liabilities:
Accounts receivable	665	166
Inventories	(3,540)	(651)
Prepaid expenses and other current assets	520	143
Other assets	1,914	32
Accounts payable	(896)	(4,685)
Deferred revenue	(2,462)	1,571
Accrued compensation	701	(439)
Accrued expenses and other liabilities	(5,171)	(13,025)
Net cash used in operating activities	(71,274)	(70,338)
Cash flows from investing activities:
Purchases of property and equipment	(9,137)	(2,679)
Net cash used in investing activities	(9,137)	(2,679)
Cash flows from financing activities:
Repayment of revolving debt facility	0	(257,454)
Payments of obligations under finance leases	(134)	(212)
Proceeds from issuance of common stock upon exercise of stock options	0	382
Proceeds from reverse recapitalization and PIPE financing	0	815,184
Payment of transaction costs related to reverse recapitalization	0	(41,655)
Net cash provided by (used in) financing activities	(134)	516,245
Net (decrease) increase in cash, cash equivalents, and restricted cash	(80,545)	443,228
Cash, cash equivalents, and restricted cash, beginning of period	297,543	74,693
Cash, cash equivalents, and restricted cash, end of period	216,998	517,921
Supplemental disclosure of cash flow information:
Cash paid for interest	21	19,329
Non-cash investing and financing activities:
Change in accounts payable balance and other liabilities related to purchase of property and equipment	(7,344)	(967)
Conversion of redeemable convertible preferred stock to common stock	0	1,812,678
Conversion of redeemable convertible preferred stock warrants to common stock warrants	0	7,267
Common stock issued in exchange for services associated with the reverse recapitalization	$ 0	$ 7,500

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Summary of Significant Accounting Policies	Organization and Summary of Significant Accounting Policies Organization View, Inc. (f/k/a CF Finance Acquisition Corp. II) and its wholly-owned subsidiaries (collectively “View” or the “Company”) headquartered in Milpitas, California, is a technology company that manufactures smart building products intended to help improve people’s health, productivity and experience, while simultaneously reducing energy consumption. View’s primary product is a proprietary electrochromic or “smart” glass panel that when combined with View’s proprietary network infrastructure and software, intelligently adjusts in response to the sun by tinting from clear to dark states, and vice versa thereby reducing heat and glare. The Company is devoting substantially all of its efforts towards the manufacturing, sale and further development of its product platforms, and marketing of both custom and standardized product solutions. On March 8, 2021 (the “Closing Date” or “Closing”), CF Finance Acquisition Corp. II (“CF II”), a Delaware corporation, consummated the previously announced merger pursuant to an Agreement and Plan of Merger, dated November 30, 2020 (the “Merger Agreement”), by and among CF II, PVMS Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of CF II (“Merger Sub”), and View, Inc. (hereinafter referred to as “Legacy View”). Pursuant to the Merger Agreement, a business combination between CF II and Legacy View was effected through the merger of Merger Sub with and into Legacy View, with Legacy View (the “Business Combination”) surviving as the surviving company and as a wholly-owned subsidiary of CF II (the “Merger” and collectively with the other transactions described in the Merger Agreement, the “Transactions”). On the Closing Date, CF II changed its name from CF Finance Acquisition Corp. II to View, Inc. and Legacy View changed its name to View Operating Corporation. On March 8, 2021, the Company completed the Transactions and raised net proceeds of $771.3 million, net of transaction costs of $43.9 million. In conjunction with the Transactions, the Company repaid in full the revolving debt facility of $276.8 million, including accrued interest and future interest through maturity of the notes of $26.8 million. See Note 2 for additional information regarding the reverse recapitalization. Basis of Presentation The condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting and are unaudited. The Company’s condensed consolidated financial statements include the accounts of View, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on December 31. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021, included in the Company’s 2021 Annual Report on Form 10-K filed with the SEC on June 15, 2022 (the “2021 Annual Report on Form 10-K”). The information as of December 31, 2021 included in the condensed consolidated balance sheets was derived from those audited consolidated financial statements. As a result of the Transactions completed on March 8, 2021, prior period share and per share amounts presented in the accompanying condensed consolidated financial statements and these related notes have been retroactively converted in an amount determined by application of the exchange ratio of 0.02325 (“Exchange Ratio”), which was based on Legacy View’s implied price per share prior to the Merger. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and included herein reflect all adjustments, including normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of March 31, 2022, and the results of operations and cash flows for the three months ended March 31, 2022. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the full year or any other future interim or annual periods. All amounts are presented in U.S. dollars ($). Liquidity and Going Concern The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Since inception, the Company has not achieved profitable operations or positive cash flows from operations. The Company’s accumulated deficit totaled $2,339.7 million as of March 31, 2022. For the three months ended March 31, 2022, we had a net loss of approximately $82.4 million and negative cash flows from operations of approximately $71.3 million. In addition, for the three months ended March 31, 2021, we had a net loss of approximately $74.0 million and negative cash flows from operations of approximately $70.3 million. Cash and cash equivalents as of March 31, 2022 was $200.5 million. The Company has historically financed its operations through the issuance and sale of redeemable convertible preferred stock, the issuance of debt financing, the gross proceeds associated with the Merger and revenue generation from product sales. The Company’s continued existence is dependent upon its ability to obtain additional financing, enter into profitable sales contracts and generate sufficient cash flow to meet its obligations on a timely basis. The Company’s business will require significant amounts of capital to sustain operations and the Company will need to make the investments it needs to execute its long-term business plans. The Company has determined that there is substantial doubt about its ability to continue as a going concern, as the Company does not currently have adequate financial resources to fund its forecasted operating costs and meet its obligations for at least twelve months from the filing of this Quarterly Report on Form 10-Q. While the Company will seek to raise additional capital, there can be no assurance the necessary financing will be available on terms acceptable to the Company, or at all. If the Company raises funds by issuing equity securities, dilution to stockholders may result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of holders of common stock. If we raise funds by issuing debt securities, these debt securities would have rights, preferences and privileges senior to those of preferred and common stockholders. The terms of debt securities or borrowings could impose significant restrictions on our operations. The capital markets have in the past, and may in the future, experience periods of upheaval that could impact the availability and cost of equity and debt financing. In addition, recent and anticipated future increases in federal fund rates set by the Federal Reserve, which serve as a benchmark for rates on borrowing, will impact the cost of debt financing. If we are unable to obtain adequate capital resources to fund operations, we would not be able to continue to operate our business pursuant to our current business plan, which would require us to modify our operations to reduce spending to a sustainable level by, among other things, delaying, scaling back or eliminating some or all of our ongoing or planned investments in corporate infrastructure, business development, sales and marketing, research and development and other activities, which would have a material impact on our operations and our ability to increase revenues, or we may be forced to discontinue our operations entirely. Summary of Significant Accounting Policies There have been no significant changes to the significant accounting policies disclosed in Note 1 of the audited consolidated financial statements as of and for the year ended December 31, 2021 included in the Company’s 2021 Annual Report on Form 10-K. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are held by domestic financial institutions with high credit standings. Such deposits may, at times, exceed federally insured limits. As of March 31, 2022, the Company has not experienced any losses on its deposits of cash and cash equivalents. For the three months ended March 31, 2022, three customers represented greater than 10.0% of total revenue, each accounting for 18.0%, 15.7% and 10.8% of total revenue. For the three months ended March 31, 2021, two customers represented greater than 10.0% of total revenue, each accounting for 31.8% and 10.3% of total revenue. Two customers accounted for 34.6% of accounts receivable, net as of March 31, 2022, including 17.9% and 16.7%, respectively. Four customers accounted for 53.0% of accounts receivable, net as of December 31, 2021, including 15.2%, 13.3%, 12.8% and 11.8%, respectively. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. Certain materials used by the Company in the manufacturing of its products are purchased from a limited number of suppliers. Shortages could occur in these materials due to an interruption of supply or increased demand in the industry. For the three months ended March 31, 2022, three suppliers accounted for 31.3%, 16.7% and 13.8% of total purchases. For the three months ended March 31, 2021, two suppliers accounted for 37.3% and 12.7% of total purchases. Segment Reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company operates and manages its business as one reportable and operating segment. The Company’s chief executive officer, who is the chief operating decision maker, reviews financial information on a consolidated basis for purposes of allocating resources and assessing performance. All material long-lived assets are maintained in the United States. See “Concentration of Credit Risk and Other Risks and Uncertainties” for further information on revenue by customer and Note 3 for further information on revenue by geography and categorized by products and services. Recent Accounting Pronouncements, Adopted In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt — Modifications and Extinguishments (Subtopic 470-50), Compensation — Stock Compensation (Topic 718), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (“ASU No. 2021-04”). This ASU provides a principles-based framework for issuers to account for a modification or exchange of freestanding equity-classified written call options that remain equity classified after the modification or exchange based on the economic substance of the modification or exchange. The Company has adopted this standard as of the first quarter of 2022 and the adoption did not have an impact on the condensed consolidated financial statements. Recent Accounting Pronouncements, Not Yet Adopted In August 2020, the FASB issued No. ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”) . This ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (“EPS”) calculation in certain areas. ASU 2020-6 is effective for fiscal years beginning after December 15, 2023 including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating whether this guidance will have a significant impact on its condensed consolidated financial statements.

Reverse Recapitalization

Reverse Recapitalization	3 Months Ended
	Mar. 31, 2022
Reverse Recapitalization [Abstract]
Reverse Recapitalization	Reverse RecapitalizationIn connection with the Merger, the Company raised $815.2 million of gross proceeds including the contribution of $374.1 million of cash held in CF II’s trust account from its initial public offering, net of redemptions of CF II Class A Common Stock held by CF II’s public stockholders of $125.9 million, $260.8 million of private investment in public equity (“PIPE”) at $10.00 per share of CF II’s Class A Common Stock, and $180.3 million of additional PIPE at $11.25 per share of CF II’s Class A Common Stock. Immediately before the Merger, all of Legacy View’s outstanding warrants were net exercised for shares of Legacy View Class A common stock. Upon consummation of the Merger, all holders of Legacy View Class A common stock and redeemable convertible preferred stock received shares of the Company’s Class A common stock at a deemed value of $10.00 per share after giving effect to the Exchange Ratio based on the completion of the following transactions contemplated by the Merger Agreement: • the cancellation of each issued and outstanding share of Legacy View Capital Stock and the conversion into the right to receive a number of shares of View, Inc. Class A Common Stock equal to the Exchange Ratio; • the conversion of all outstanding Legacy View Warrants into warrants exercisable for shares of View Inc. Class A Common Stock with the same terms except for the number of shares exercisable and the exercise price, each of which was adjusted using the Exchange Ratio; and • the conversion of all outstanding vested and unvested Legacy View Options into options exercisable for shares of View Inc. Class A Common Stock with the same terms except for the number of shares exercisable and the exercise price, each of which was adjusted using the Exchange Ratio. In connection with the Merger, the Company incurred $43.9 million of Transaction costs, consisting of underwriting, legal, and other professional fees, of which $42.4 million was recorded to additional paid-in capital as a reduction of proceeds and the remaining $1.5 million was expensed immediately. The number of shares of Class A common stock issued immediately following the consummation of the Merger on March 8, 2021 was: Number of Shares Common stock of CF II outstanding prior to the Merger 1 62,500,000 Less redemption of CF II shares (12,587,893) CF II Sponsor Earnout Shares outstanding prior to the Merger 1,100,000 Common stock of CF II 51,012,107 Shares issued in PIPE financing 42,103,156 Shares issued for in kind banker fee payment 750,000 Merger and PIPE financing shares 42,853,156 Legacy View shares converted 2 123,211,449 Total 217,076,712 1 Includes CF II Class A shareholders of 50,000,000 and CF II Class B shareholders of 12,500,000. 2 The number of Legacy View shares was determined from the 76,565,107 shares of Legacy View common stock and 5,222,852,052 shares of Legacy View redeemable convertible preferred stock outstanding, which were converted to an equal number of shares of Legacy View common stock upon the closing of the Merger, and then converted at the Exchange Rate to Class A common stock of the Company. All fractional shares were rounded down to the nearest whole share. The Merger was accounted for as a reverse recapitalization because Legacy View was determined to be the accounting acquirer. Under this method of accounting, CF II was treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of Legacy View with the Merger treated as the equivalent of Legacy View issuing stock for the net assets of CF II, accompanied by a recapitalization. The net assets of CF II will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are those of Legacy View. Legacy View was determined to be the accounting acquirer based on the following facts and circumstances: • Legacy View stockholders comprised a relative majority of voting power of View; • Legacy View had the ability to nominate a majority of the members of the board of directors of View; • Legacy View’s operations prior to the acquisition comprising the only ongoing operations of View; • Legacy View’s senior management comprising a majority of the senior management of View; and • View substantially assuming the Legacy View name.

Revenue

Revenue	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The Company disaggregates revenue between products and services, as well as by major product offering and by geographic market that depict the nature, amount, and timing of revenue and cash flows. The following table summarizes the Company’s revenue by products and services (in thousands): Three Months Ended March 31, 2022 2021 Revenue: Products $ 15,533 $ 9,711 Services 1,479 58 Total $ 17,012 $ 9,769 View Smart Glass contracts to provide CSS include the sale of both products and services. These services primarily relate to CSS installation and commissioning and are presented in the table above as Services. Also included within Services in the table above are revenues associated with extended or enhanced warranties. View Smart Glass contracts to provide IGUs, View Smart Building Platform contracts and View Smart Building Technologies contracts relate to the sale of products. The following table summarizes the Company's revenue by major product offering (in thousands): Three Months Ended March 31, 2022 2021 Revenue: Smart Glass $ 5,183 $ 8,215 Smart Building Platform 9,206 — Smart Building Technologies 2,623 1,554 Total $ 17,012 $ 9,769 During the three months ended March 31, 2022 and 2021, the Company recognized a total of $2.5 million and $2.1 million, respectively, for initial contract loss accruals, and incurred $4.0 million of previously accrued losses in the three months ended March 31, 2022, resulting in a decrease to the accrual. Changes in estimated costs to complete View Smart Building Platform projects and the related effect on revenue are recognized using a cumulative catch-up adjustment which recognizes in the current period the cumulative effect of the changes on current and prior periods based on a contract’s progress towards fulfillment of the performance obligation. The cumulative catch-up adjustments were $0.9 million and nil for the three months ended March 31, 2022 and 2021, respectively. The balance of estimated contract losses for work that had not yet been completed totaled $18.3 million and $20.7 million as of March 31, 2022 and December 31, 2021, respectively. The following table summarizes the Company’s revenue by geographic area, which is based on the shipping address of the customers (in thousands): Three Months Ended March 31, 2022 2021 Revenue: United States $ 16,284 $ 9,665 Canada 718 104 Other 10 — Total $ 17,012 $ 9,769 Remaining Performance Obligations The Company’s IGU contracts are short-term in nature and the practical expedient has been applied. The Company’s performance obligations in CSS contracts are generally short-term in nature, for which the practical expedient has been applied, with the exception of commissioning services, which are provided at the end of a construction project. Revenue for commissioning services performance obligations is not material. The Company’s performance obligations in Smart Building Platform contracts are longer-term in nature, however many of these contracts provide the customer with a right to cancel or terminate for convenience with no substantial penalty. The transaction price allocated to remaining performance obligations for non-cancelable Smart Building Platform contracts as of March 31, 2022 was $7.9 million that the Company expects to recognize as it satisfies the performance obligations over the next 12 to 24 months which are, among other things, dependent on the construction schedule of the site for which the Company's products and services are provided. The Company’s performance obligations in Smart Building Technologies contracts are generally short-term in nature, for which the practical expedient has been applied. Contract Assets and Liabilities Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing, where payment is conditional, as well as retainage for amounts that we have billed to the customer but are being held for payment by the customer pending satisfactory completion of the project. Current contract assets as of March 31, 2022 and December 31, 2021 were $12.5 million and $11.5 million, respectively, and were included in other current assets. The increase in 2021 primarily relates to contract assets associated with View Smart Building Platform contracts, which commenced in 2021. The progress billing schedules for these contracts result in timing differences as compared to the Company’s satisfaction of its performance obligation. Non-current contract assets as of March 31, 2022 and December 31, 2021 were $0.7 million and $0.7 million, respectively, and were included in other assets. Contract liabilities relate to amounts invoiced or consideration received from customers, typically for the Company’s CSS contracts, in advance of the Company’s satisfaction of the associated performance obligation. Such contract liabilities are recognized as revenue when the performance obligation is satisfied. Contract liabilities are presented as deferred revenue on the condensed consolidated balance sheets.

Fair Value

Fair Value	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value	Fair ValueFair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be either recorded or disclosed at fair value, the Company considers the principal or most advantageous market in which it would transact, and it also considers assumptions that market participants would use when pricing the asset or liability. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. U.S. GAAP establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: Level 1 Observable inputs such as quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 Inputs other than the quoted prices in active markets that are observable either directly or indirectly. Level 3 Unobservable inputs in which there are little or no market data and which require the Company to develop its own assumptions. At Closing, the Sponsor subjected 4,970,000 shares (“Sponsor Earn-Out Shares”) to vesting and potential forfeiture (and related transfer restrictions) based on a five year post-Closing earnout, with (a) 50% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $12.50 for 5 out of any 10 trading days, (b) 25% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $15.00 for 5 out of any 10 trading days and (c) 25% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $20.00 for 5 out of any 10 trading days, in each case, subject to early release for a sale, change of control or going private transaction or delisting after the Closing (collectively, the “Earn-Out Triggering Events”). These Sponsor Earn-Out Shares are accounted for as liability classified instruments because the Earn-Out Triggering Events that determine the number of Sponsor Earn-Out Shares to be earned back by the Sponsor include events that are not solely indexed to the common stock of the Company. As of March 31, 2022, the Earn-Out Triggering Events were not achieved for any of the tranches and as such the Company adjusted the carrying amount of the liability to its estimated fair value. The following table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands): March 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 167,522 $ — $ — $ 167,522 Total cash equivalents 167,522 — — 167,522 Restricted cash: Certificates of deposit 16,466 — 16,466 Total assets measured at fair value $ 167,522 $ 16,466 $ — $ 183,988 Sponsor earn-out liability — — 3,331 3,331 Private warrants liability $ — $ — $ 86 $ 86 Total liabilities measured at fair value $ — $ — $ 3,417 $ 3,417 December 31, 2021 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 247,500 $ — $ — $ 247,500 Total cash equivalents 247,500 — — 247,500 Restricted cash: Certificates of deposit — 16,462 — 16,462 Total assets measured at fair value $ 247,500 $ 16,462 $ — $ 263,962 Sponsor earn-out liability $ — $ — $ 7,624 $ 7,624 Private warrants liability $ 174 174 Total liabilities measured at fair value $ — $ — $ 7,798 $ 7,798 The following table provides a reconciliation of the beginning and ending balances for the level 3 financial liabilities measured at fair value using significant unobservable inputs (in thousands): Sponsor Private Balance as of December 31, 2021 $ 7,624 $ 174 Change in fair value 4,293 88 Balance as of March 31, 2022 $ 11,917 $ 262 Sponsor Earn-out Shares, Private Warrants and redeemable convertible preferred stock warrants are or were subject to remeasurement to fair value at each balance sheet date. See Note 2 for additional information regarding the reverse recapitalization and the conversion of the redeemable convertible preferred stock warrants at the time of the Merger. Changes in fair value as a result of the remeasurement are recognized in gain on fair value change, net in the condensed consolidated statements of operations. The following table summarizes the (gain) loss on fair value change, net (in thousands): Three Months Ended March 31, 2022 2021 Sponsor Earn-out Liability $ (4,293) $ (2,460) Private Warrants (88) 103 Redeemable Convertible Preferred Stock Warrants — (5,056) Gain on fair value change, net $ (4,381) $ (7,413) Valuation of Sponsor Earn-Out liability The estimated fair value of the Sponsor Earn-Out Shares was determined using a Monte Carlo simulation valuation model using the following assumptions: March 31, 2022 December 31, 2021 Stock price $1.84 $3.91 Expected volatility 73.25% 52.50% Risk free rate 2.44% 1.12% Expected term (in years) 3.9 4.2 Expected dividends 0% 0% Current stock price: The stock price was based on the closing price as of the valuation date. Expected volatility: The volatility rate was determined using a Monte Carlo simulation to estimate the implied volatility of the warrants as such warrants are publicly traded. Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve for zero-coupon U.S. Treasury notes with maturities corresponding to the remaining expected term of the earnout period. Expected term: The expected term is the remaining contractual term of the earnout period. Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends in the foreseeable future. Valuation of Private Warrants The estimated fair value of the Private Warrants was determined using the Black-Scholes option-pricing model using the following assumptions: March 31, 2022 December 31, 2021 Stock price $1.84 $3.91 Expected volatility 73.30% 52.50% Risk free rate 2.44% 1.04% Expected term (in years) 3.4 3.7 Expected dividends 0% 0% Other

Other Balance Sheet Information

Other Balance Sheet Information	3 Months Ended
	Mar. 31, 2022
Payables and Accruals [Abstract]
Other Balance Sheet Information	Other Balance Sheet Information Cash, Cash Equivalents and Restricted Cash Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): March 31, 2022 December 31, 2021 Cash $ 33,010 $ 33,581 Cash equivalents 167,522 247,500 Cash and cash equivalents 200,532 281,081 Restricted cash 16,466 16,462 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 216,998 $ 297,543 Accounts Receivable, Net of Allowances In the quarter ended March 31, 2022, the Company made no adjustments in the allowance for credit losses. The Company regularly reviews accounts receivable for collectability and establishes or adjusts the allowance for credit losses as necessary using the specific identification method based on the available facts. The allowance for credit losses totaled $0.7 million at both March 31, 2022 and December 31, 2021. Inventories Inventories consist of finished goods which are stated at the lower of cost or net realizable value. Costs are measured on a first-in, first out basis using standard cost, which approximates actual cost. Net realizable value is the estimated selling price of the Company’s products in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Inventories are written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value, or are in excess of expected demand. Once inventory is written down, its new value is maintained until it is sold, scrapped, or written down for further valuation losses. The valuation of inventories requires the Company to make judgments based on currently available information about the likely method of disposition and current and future product demand relative to the remaining product life. Inventory valuation losses are classified as cost of revenue in the condensed consolidated statements of comprehensive loss. The Company recorded inventory impairments of $6.3 million and $0.5 million as of March 31, 2022 and 2021, respectively. Impairment of Long-Lived Assets The Company evaluates long-lived assets for impairment whenever events indicate that a potential impairment may have occurred. If such events arise, the Company will compare the carrying amount of the asset group comprising the long-lived assets to the estimated future undiscounted cash flows expected to be generated by the asset group. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the asset group, an impairment charge is recorded as the amount by which the carrying amount of the asset group exceeds the fair value of the assets, as based on the expected discounted future cash flows attributable to those assets. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell. The Company regularly reviews its long-lived assets for triggering events or other circumstances that could indicate impairment. As of March 31, 2022, no triggering events or other circumstances were identified. There were no impairments of long-lived assets during the three months ended March 31, 2022 and 2021. Goodwill and Other Intangible Assets From time to time, the Company makes acquisitions of companies related to existing, complementary or new markets. During fiscal year 2021, the Company completed two acquisitions, which were immaterial to its financial position, results of operations and cash flows. There were no acquisitions completed in the three months ended March 31, 2022. Acquisition-related costs are included in general and administrative expenses in the consolidated statements of operations and were nil for the three months ended March 31, 2022 and 2021.

Product Warranties

Product Warranties	3 Months Ended
	Mar. 31, 2022
Guarantees and Product Warranties [Abstract]
Product Warranties	Product Warranties The Company provides a standard assurance type warranty that its insulating glass units (“IGUs”) will be free from defects in materials and workmanship for generally 10 years from the date of delivery to customers. IGUs with sloped or laminated glass generally have a warranty of 5 or 10 years. Control systems associated with the sale of Controls, Software and Services (“CSS”) typically have a 5-year warranty. As part of the Company’s Smart Building Platform contracts, the Company generally warrants that the workmanship of the sub-assemblies and installation of the Smart Building Platform are free from defects and in conformance with the contract documents for one year from completion. In resolving warranty claims, the Company’s standard warranty terms provide that the Company generally has the option of repairing, replacing or refunding the selling price of the covered product. The Company has not been requested to and has not provided any refunds, which would be treated as a reduction to revenue, as of March 31, 2022. The Company accrues for estimated claims of defective products at the time revenue is recognized based on historical warranty claims rates. The Company’s estimated costs for standard warranty claims are based on future estimated costs the Company expects to incur to replace the IGUs or control systems multiplied by the estimated IGU or control system warranty claims, respectively, based on warranty contractual terms and business practices. The total warranty liability included $6.0 million and $6.1 million as of March 31, 2022 and December 31, 2021, respectively, related to this standard assurance warranty. In 2019, the Company identified a quality issue with certain material purchased from one of its suppliers utilized in the manufacturing of certain IGUs. The Company stopped using the affected materials upon identification of the quality issue in 2019. The Company has replaced and expects to continue to replace the affected IGUs for the remainder of the period covered by the warranty. The Company developed a statistical model to analyze the risk of failure of the affected IGUs related to this quality issue and predict the potential number of future failures that may occur during the remaining warranty period, as well as the timing of the expected failures. Management judgment is necessary to determine the distribution fit and covariates utilized in the statistical model, as well as the relative tolerance to declare convergence. The statistical model considered the volume of units sold, the volume of unit failures, data patterns, and other characteristics associated with the failed IGUs as well as the IGUs that had not yet failed as of each financial reporting period. These characteristics include, but are not limited to, time to failure, manufacture date, location of installation, and environmental factors. Based on this analysis, the Company has recorded a specific warranty liability using the estimated number of affected IGUs expected to fail in the remaining warranty period and applying estimated costs the Company expects to incur to replace the IGUs based on warranty contractual terms and business practices. The total warranty liability included $34.9 million and $36.2 million as of March 31, 2022 and December 31, 2021, respectively, related to these IGUs. The Company monitors warranty obligations and may make adjustments to its warranty liabilities if actual costs of product repair and replacement are significantly higher or lower than estimated. Accruals for anticipated future warranty costs are recorded to cost of revenue in the condensed consolidated statements of comprehensive loss and included in other current liabilities and other liabilities on the condensed consolidated balance sheet. Warranty liabilities are based on estimates of failure rates and future costs to settle warranty claims that are updated periodically, taking into consideration inputs such as changes in the volume of claims compared with the Company’s historical experience, and changes in the cost of servicing warranty claims. The estimated cost includes the Company’s expectations regarding future total cost of replacement, as well as fixed cost absorption as production increases. The Company accounts for the effect of changes in estimates prospectively. Changes in warranty liabilities are presented below (in thousands): March 31, 2022 December 31, 2021 Beginning balance $ 42,256 $ 47,678 Accruals for warranties issued 618 1,551 Changes to estimates of volume and costs — 1,234 Settlements made (1,918) (8,207) Ending balance $ 40,956 $ 42,256 Warranty liability, current, beginning balance $ 8,868 $ 8,864 Warranty liability, noncurrent, beginning balance $ 33,388 $ 38,814 Warranty liability, current, ending balance $ 8,987 $ 8,868 Warranty liability, noncurrent, ending balance $ 31,969 $ 33,388 During the three months ended March 31, 2022 and 2021, the Company recorded a charge to Cost of revenues of $0.6 million and $0.4 million, respectively, related to adjustments to the warranty liability. Considering the uncertainty inherent in the failure analysis, including the actual timing of the failures and the number of defective IGUs, as well as uncertainty regarding future supply chain costs and production volumes that may impact the projected costs to replace defective IGUs in future years, it is reasonably possible that the amount of costs to be incurred to replace the defective IGUs could ultimately be materially different from the estimate. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs. If actual warranty costs differ substantially from the Company’s estimates, revisions to the estimated warranty liability would be required, which could have a material adverse effect on the Company’s business, financial condition and results of operations.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Indemnifications From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify the Company's officers, directors, and employees for liabilities arising out of their employment relationship. Generally, a maximum obligation under these contracts is not explicitly stated. Because the maximum amounts associated with these agreements are not explicitly stated, the overall maximum amount of the obligation cannot be reasonably estimated. The Company has not been required to make payments under these obligations, and no liabilities have been recorded for these obligations on the Company's condensed consolidated balance sheets. Standby Letter of Credit During the course of business, the Company’s bank issues standby letters of credit on behalf of the Company to certain vendors and other third parties of the Company. As of both March 31, 2022 and December 31, 2021, the total value of the letters of credit issued by the bank is $16.5 million. No amounts have been drawn under the standby letters of credit. Commitments In June 2021, the Company entered into a promissory note with one of its customers pursuant to which the customer may draw amounts in a maximum aggregate principal amount of $10.0 million. The amount of the draws are limited to amounts incurred by subcontractors contracted by the Company in relation to the project. The note is not a revolving facility, which means that outstanding amounts under the note that are repaid cannot be re-borrowed. The promissory note has a maturity date set at the fourth anniversary of the date of the first advance to the customer. The promissory note bears no interest during the period between the first advance to the customer and the thirty-first month following the first advance, with interest increasing to an annual rate of 3.5% thereafter. As of March 31, 2022, the customer had requested zero advances on the promissory note. Litigation and Environmental Settlements In December 2014, the Company finalized the terms of a litigation settlement with a third party where the Company agreed to pay the other party a total of $32.0 million periodically over the next ten years. The Company recorded the present value of future payments as a liability and records interest expense, included in interest and other, net in the condensed consolidated statements of comprehensive loss, as it accretes the liability. The balance of the litigation settlement liability is reflected on our condensed consolidated balance sheets as follows (in thousands): March 31, December 31, 2021 Litigation settlement liability - current $ 3,000 $ — Litigation settlement liability - non-current 5,082 7,834 Total litigation settlement liability $ 8,082 $ 7,834 In September and August of 2021, the Mississippi Commission on Environmental Quality (“MCEQ”), Desoto County Regional Utility Authority (“DCRUA”) and the City of Olive Branch, Mississippi (“Olive Branch”), each issued notices and orders to the Company with respect to its discharges of water from its Olive Branch facility into the publicly owned treatment works (“POTW”) of DCRUA and Olive Branch without first obtaining a pretreatment permit. In August 2021, a Subpoena to Testify Before a Grand Jury was issued out of the United States District Court for the Northern District of Mississippi (“Subpoena”) to the Company requiring it to produce to the Environmental Protection Agency (“EPA”) various documents relating to environmental matters at its Olive Branch facility, including but not limited to hazardous waste records, air emissions records, storm water discharges records and wastewater disposal records. The Company has cooperated fully with each such notice, order and Subpoena. On April 13, 2022, the Company and the United States Attorney’s Office for the United States District Court for the Northern District of Mississippi agreed in principle to the terms of a global settlement resolving the prospect of claims and charges against the Company relating to all prior discharges of water into the POTW of DCRUA and Olive Branch without first obtaining a pretreatment permit. The principal terms of the settlement are: 1. the Company pleading guilty to a single misdemeanor count for negligently discharging wastewater to a POTW without first obtaining a pretreatment permit in violation of 33 U.S.C. § 1319(c)(1)(A); 2. the Company paying a fine of $3.0 million over a three-year period in equal installments of $1.0 million to the federal government; 3. the Company paying a special assessment of $125 to the federal government pursuant to 18 U.S.C. § 3013(a)(1)(B); 4. the Company entering a separate civil Agreed Order with the MCEQ that requires the payment of a separate civil penalty of $1.5 million; 5. the Company making a separate community service payment in the amount of $0.5 million to DCRUA, to be used for the sole purpose of expanding wastewater treatment capacity in DeSoto County, Mississippi, within 30 days of entering the Plea Agreement; 6. the Company implementing an environmental management system that conforms to ISO 14001:2015 standards or a similar environmental management system approved by the United States Environmental Protection Agency, which is expected to result in $0.3 million in consulting and personnel costs; 7. the Company implementing agreed upon wastewater reduction plans, which is expected to result in approximately $2.0 million in capital expenditures to install a wastewater treatment and recycling system; 8. the Company obtaining a pretreatment permit from MDEQ, or entering an Agreed Order with MCEQ and operating in compliance with that Agreed Order until a permit can be obtained; 9. the Company obtaining wastewater discharge permits from DCRUA and Olive Branch, or entering into Consent/Compliance Order(s) or Agreement(s) with DCRUA and Olive Branch that are consistent with any Agreed Order entered with MCEQ and operating in compliance with such Consent/Compliance Order(s) or Agreement(s) until permits can be obtained; and 10. the Company agreeing to probation for three years. The terms of the Plea Agreement are subject to the approval of the United States District Court for the Northern District of Mississippi. View is in the process of coordinating with MDEQ and the local authorities with respect to the civil orders and/or agreements contemplated by the settlement terms, including obtaining a pretreatment permit from MCEQ, which has not been granted as of the date of this Report. The Plea Agreement will be presented to the Court for approval following these efforts. The date for presentation of the Plea Agreement to the Court has not yet been determined. The Company has recognized the $5.0 million of penalties it expects to incur in conjunction with this environmental settlement over the next three years. The balance of the environmental settlement liability is reflected on our condensed consolidated balance sheets as follows (in thousands): March 31, December 31, 2021 Environmental settlement liability - current $ 2,950 $ 2,950 Environmental settlement liability - non-current 2,000 2,000 Total environmental settlement liability $ 4,950 $ 4,950 Litigation From time to time, the Company is subject to claims, litigation, internal or governmental investigations, including those related to labor and employment, contracts, intellectual property, environmental, regulatory compliance, commercial matters and other related matters, some of which allege substantial monetary damages and claims. Some of these actions may be brought as class actions on behalf of a class or purported class of employees. The Company is also defendants in judicial and administrative proceedings involving matters incidental to our business. Legal expenses are expensed as incurred. The Company accrues a charge when management determines that it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. When a loss is probable, the Company records an accrual based on the reasonably estimable loss or range of loss. When no point of loss is more likely than another, the Company records the lowest amount in the estimated range of loss and discloses the estimated range. The Company does not record liabilities for reasonably possible loss contingencies but does disclose a range of reasonably possible losses if they are material and the Company is able to estimate such a range. If the Company cannot provide a range of reasonably possible losses, the Company explains the factors that prevent it from determining such a range. The Company regularly evaluates current information available to it to determine whether an accrual should be established or adjusted. The ultimate outcome of legal proceedings involves judgments, estimates, and inherent uncertainties and cannot be predicted with certainty. Should the ultimate outcome of any legal matter be unfavorable, the Company's business, financial condition, results of operations, or cash flows could be materially and adversely affected. The Company may also incur substantial legal fees, which are expensed as incurred, in defending against legal claims. Securities Litigation On August 18, 2021, plaintiff Asif Mehedi filed a putative securities class action in the United States District Court for the Northern District of California ( Mehedi v. View, Inc. f/k/a CF Finance Acquisition Corp. II et al. (No. 5:21CV06374, N.D. Cal.)) alleging violations of the federal securities laws by the Company, Rao Mulpuri, and Vidul Prakash. The complaint alleges that defendants violated Section 10(b) of the Securities Exchange Act of 1934 (and SEC Rule 10b-5 promulgated thereunder) and that Mulpuri and Prakash violated Section 20(a) of the Exchange Act. The complaint asserts claims on behalf of a putative class of persons who acquired the Company’s stock between November 30, 2020 and August 16, 2021. The complaint alleges that defendants failed to disclose to investors that the Company had not properly accrued warranty costs related to its product; that there was a material weakness in the Company’s internal control over financial reporting related to warranty accrual; that the Company’s financial results for prior periods were misstated as a result; and that defendants’ positive statements about the Company’s business were materially misleading. The complaint alleges that the foregoing statements caused the price of the Company’s stock to be inflated and that class members were damaged when the price of the Company’s stock declined on August 16, 2021, when the Company announced an independent investigation concerning the adequacy of the Company’s previously disclosed warranty accrual. Plaintiff seeks unspecified compensatory damages and costs, including attorneys’ and expert fees. On February 8, 2022, the Court appointed Stadium Capital LLC lead plaintiff and denied the competing motion of Sweta Sonthalia. On March 14, 2022, Ms. Sonthalia filed a Petition for a Writ of Mandamus, asking the Ninth Circuit Court of Appeals to vacate the lead plaintiff order. On April 11, 2022, the district court denied Ms. Sonthalia’s motion to stay proceedings in the district court pending disposition of the writ petition. The writ petition is now fully briefed in the Ninth Circuit and oral argument has been scheduled for August 11, 2022. Pursuant to a stipulated schedule, Stadium Capital will file an amended complaint no later than 30 days after View files its Restatement with the SEC; defendants will file an answer or motion(s) to dismiss within 60 days of the filing of the amended complaint; Stadium Capital will file its opposition(s) to the motion(s) within 30 days of the filing of the motion(s) to dismiss; and defendants will file any reply in support of the motion(s) to dismiss within 30 days of the filing of the opposition brief. Given the early stage of this matter, we cannot reasonably estimate the possible loss (or range of loss), if any, at this time; therefore, a liability has not been recorded as of March 31, 2022. Derivative Litigation On December 6, 2021, a purported Company shareholder filed a verified stockholder derivative complaint (nominally on behalf of the Company) against Rao Mulpuri, Nigel Gormly, Harold Hughes, Tom Leppert, Toby Cosgrove, Lisa Picard, Julie Larson-Green, and Vidul Prakash ( Jacobson v. Mulpuri, et al. (No. 1:21CV01719, D. Del.)). The complaint alleges that Mulpuri and Prakash violated Sections 10(b) and 21D of the Exchange Act, and asserts claims against the director defendants for breach of fiduciary duty and waste of corporate assets. The complaint alleges that defendants Mulpuri, Gormly, Hughes, Leppert, Cosgrove, Picard, and Larson-Green failed to prevent the Company from making false statements regarding the Company’s business results and prospects and that the Company has been harmed by incurring legal fees and potential liability in investigations and lawsuits. The complaint seeks unspecified damages and costs, a judgment directing the Company to reform its corporate governance and internal procedures, and unspecified restitution from defendants to the Company. On February 14, 2022, the Court entered the parties’ stipulation staying the litigation until fifteen days after the earliest of: (a) dismissal with prejudice of the Mehedi v. View securities class action and exhaustion of all appeals, or dismissal by settlement; (b) the motion(s) to dismiss Mehedi v. View are denied; or (c) either party gives notice that it no longer consents to the stay. On May 24, 2022, a different purported Company shareholder filed another verified stockholder derivative complaint (nominally on behalf of the Company) against Mulpuri, Gormly, Hughes, Leppert, Cosgrove, Picard, Larson-Green, and Prakash ( Damidi v. Mulpuri et al. (No. 1:22CV00675, D. Del.)). The complaint asserts claims for violation of Sections 10(b) and 21D of the Exchange Act, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unjust enrichment, and waste of corporate assets. The complaint alleges that defendants Mulpuri, Gormly, Hughes, Leppert, Cosgrove, Picard, and Larson-Green failed to prevent the Company from making false statements regarding the Company’s business results and prospects and that the Company has been harmed by incurring legal fees and potential liability in investigations and lawsuits. The complaint seeks unspecified damages and costs, punitive damages, and unspecified restitution from defendants to the Company. The Damidi action has been docketed as related to the Jacobson action. Given the early stage of this matter, we cannot reasonably estimate the possible loss (or range of loss), if any, at this time; therefore, a liability has not been recorded as of March 31, 2022. Government Investigation On November 9, 2021, we announced that we had voluntarily reported to the SEC that the Audit Committee of the Company’s Board of Directors was conducting an independent, internal investigation into the adequacy of the Company’s previously reported warranty accrual. In January 2022, we were informed that the SEC is conducting a formal investigation of this matter. We have cooperated with the SEC’s investigation and intend to continue doing so. Given the early stage of this matter, we cannot reasonably estimate the possible loss (or range of loss), if any, at this time; therefore, a liability has not been recorded as of March 31, 2022.

Debt

Debt	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt Debt outstanding consisted of the following (in thousands): Interest Rate March 31, December 31, 2021 Term loan, due June 30, 2032 0% $ 15,430 $ 15,430 Total debt 15,430 15,430 Debt, current 1,470 1,470 Debt, non-current $ 13,960 $ 13,960 Principal payments on all debt outstanding as of March 31, 2022 are estimated as follows (in thousands): Year Ending December 31, Total 2022 (remaining nine months) $ 1,470 2023 1,470 2024 1,470 2025 1,470 2026 1,470 Thereafter 8,080 Total $ 15,430 Term Loan On November 22, 2010, the Company entered into a debt arrangement with a lender, in an amount of $40.0 million (“Term Loan”), for the purpose of financing equipment and tenant improvements at its manufacturing facility in Olive Branch, Mississippi. Pursuant to the original terms, the loan provides for interest-free debt to be repaid in semi-annual payments due on June 30 and December 31 each year. The loan was originally being paid over 24 semi-annual installments through June 30, 2024. On October 22, 2020, the Company entered into an amended and restated debt arrangement with the lender. The amended and restated debt arrangement temporarily suspended the payments. Starting June 30, 2022, the Company is required to make semi-annual payments of $0.7 million through June 30, 2032. The term loan agreement required the Company to invest certain amounts in land, building and equipment and create a certain number of jobs. The term loan agreement, as amended, also includes a covenant for audited consolidated financial statements to be delivered to the lender within 210 days of the Company’s fiscal year end. As of March 31, 2022, the Company was in compliance with these covenants. Revolving Debt Facility In October 2019, the Company entered into a secured revolving debt facility pursuant to which the Company may draw amounts in a maximum aggregate principal amount of $200.0 million until January 3, 2020 and $250.0 million after such date, for the purpose of paying payables and other corporate obligations. In October 2019, the Company drew a principal amount of $150.0 million under the facility with weekly maturity dates ranging from 8 days to 364 days. In May 2020, the Company drew the remaining principal amount of $100.0 million available under the facility, which was repayable on May 1, 2021. The facility's original expiration was October 22, 2023, at which time all drawn amounts were to be repaid in full. The interest rate applicable to amounts outstanding under the facility was LIBOR, plus 9.05%. As security for the payment and performance of all obligations under the facility, the Company granted the finance provider a security interest in substantially all of the Company's assets. Under the original agreement, repaid principal amounts became immediately available to be redrawn under the facility with maturity dates of one year through October 23, 2022. In December 2020, the Company entered into an amendment to replace thirteen weekly draws of approximately $2.9 million each, aggregating to $37.5 million in principal amount, with four notes of approximately $9.4 million each, aggregating to $37.5 million in principal amount. On March 8, 2021, upon Closing, the facility was repaid in full in the amount of $276.8 million, including accrued interest and future interest through maturity of the notes of $26.8 million prior to the expiration of the limited waiver from the finance provider. Upon repayment of its obligation, the Company recorded a debt extinguishment loss of $10.0 million, and the facility was terminated.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock On March 9, 2021, the Company’s common stock and warrants began trading on the Nasdaq Global Select Market under the ticker symbols “VIEW” and “VIEWW,” respectively. Pursuant to the Company’s certificate of incorporation, the Company is authorized to issue 600,000,000 shares of common stock with a par value of $0.0001 per share. As of March 31, 2022, the Company had 219,222,346 shares of common stock issued and outstanding. Preferred Stock Pursuant to the Company’s certificate of incorporation, the Company is authorized to issue 1,000,000 shares of preferred stock having a par value of $0.0001 per share (“View Inc. Preferred Stock”). The Company’s board of directors has the authority to issue View, Inc. Preferred Stock and to determine the rights, preferences, privileges, and restrictions, including voting rights, of those shares. As of March 31, 2022, no shares of View, Inc. Preferred Stock were issued and outstanding. Dividend Common stock is entitled to dividends when and if declared by the Company’s board of directors, subject to the rights of all classes of stock outstanding having priority rights to dividends. The Company has not paid any cash dividends on common stock to date. The Company may retain future earnings, if any, for the further development and expansion of its business and has no current plans to pay cash dividends for the foreseeable future. Any future determination to pay dividends will be made at the discretion of the Company’s board of directors and will depend on, among other things, the Company’s financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as the Company’s board of directors may deem relevant.

Stock Warrants

Stock Warrants	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Stock Warrants	Stock Warrants Public and Private Warrants Prior to the Merger, CF II issued 366,666 Private Warrants and 16,666,637 Public Warrants. Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share, subject to adjustments. The Warrants became exercisable on August 26, 2021. The Public Warrants and Private Warrants will expire five years after the Closing and five years after August 26, 2020, respectively. The Company may redeem the outstanding warrants, in whole and not in part, upon a minimum of 30 days’ prior written notice of redemption (“Redemption Period”). For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s common stock for any twenty thirty The Company may redeem the outstanding Public Warrants for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. The Private Warrants are identical to the Public Warrants except that the Private Warrants were not transferable, assignable or salable until April 7, 2021. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. As of March 31, 2022, there were 366,666 Private Warrants and 16,666,637 Public Warrants outstanding, and no Warrants had been exercised. Other Warrants Legacy View also issued redeemable convertible preferred stock and common stock warrants, to various service providers, lenders, investors, at various points in time, which were subsequently converted to the common stock warrants of the Company. Upon consummation of the Merger, each Legacy View warrant that was outstanding was assumed by CF II and converted into a common stock warrant exercisable for common stock equal to the product (rounded down to the nearest whole number) of (a) the number of shares of Legacy View capital stock subject to the Legacy View warrant immediately prior to the Merger multiplied by (b) the Exchange Ratio. Such warrants have a per share exercise price equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (i) the exercise price per share of Legacy View capital stock subject to the Legacy View warrant immediately prior to the Merger by (ii) the Exchange Ratio, and, except as specifically provided in the Merger Agreement, each warrant continues to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Legacy View warrant immediately prior to the Merger. Prior to the merger, the redeemable convertible preferred stock warrants were classified as liabilities on the condensed consolidated balance sheets. See Note 4 for a reconciliation of the beginning and ending balances for the level 3 financial liabilities measured at fair value. On December 1, 2021, in connection with the WorxWell acquisition, the Company issued 1,000,000 common stock warrants to the seller. The following table summarizes the outstanding common stock warrants: Warrant issue date Types of shares Number of Warrants Number of Warrants December 31, 2021 (As converted) Exercise Expiry Date August 2010 - June 2011 Common stock (previously Series B redeemable convertible preferred stock) 46,498 46,498 $ 15.49 March 2023 August 2011 - January 2012 Common stock (previously Series C redeemable convertible preferred stock) 53,256 53,256 18.78 March 2023 August 2012 Common stock (previously Series D redeemable convertible preferred stock) 45,388 45,388 21.60 March 2023 December 2013 Common stock (previously Series E redeemable convertible preferred stock) 63,296 63,296 25.91 March 2023 April 2015 - April 2016 Common stock (previously Series F redeemable convertible preferred stock) 45,207 45,207 38.71 Through December 2022 April 2016 - November 2018 Common stock (previously Series H redeemable convertible preferred stock) 1,135,391 1,135,391 18.93 Through November 2028 March 2017 Common stock (previously Series H redeemable convertible preferred stock) 1,849,431 1,849,431 12.91 March 2027 March 2014 Common stock 2,324 2,324 9.47 August 2023 August 2015 Common stock 12,916 12,916 11.62 December 2022 December 2018 Common stock 24,910 24,910 9.04 December 2028 August 2020 Common stock (Private Warrants) 366,666 366,666 11.50 Through March 2026 August 2020 Common stock (Public Warrants) 16,666,637 16,666,637 11.50 Through March 2026 December 2021 Common stock (in connection with the WorxWell acquisition) 1,000,000 1,000,000 $ 10.00 December 2031 Total stock warrants 21,311,920 21,311,920

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation 2018 Plan Legacy View’s 2018 Amended and Restated Equity Incentive Plan (formerly the 2009 Equity Incentive Plan), effective November 21, 2018 (the “2018 Plan”), allowed Legacy View to grant incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards and restricted stock units to eligible employees, directors, and consultants of Legacy View and any parent or subsidiary of Legacy View. In connection with the Closing of the Merger, the 2018 Plan was terminated, the remaining unallocated share reserve under the 2018 Plan was cancelled and no new awards will be granted under the 2018 Plan. 24,657,302 options (as converted, due to retroactive application of reverse recapitalization) outstanding under the 2018 Plan at Closing were assumed by the Company under the 2021 Plan (defined below). The options assumed under the 2021 Plan (defined below) generally vest 20% upon completion of one year of service and 1/60 per month thereafter or vest 25% upon completion of one year of service and 1/48 per month thereafter and generally expire 10 years from the date of grant. 2021 Plan In connection with the Closing of the Merger, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) under which 58,631,907 shares of common stock were initially reserved for issuance. The 2021 Plan permits the grant of incentive stock options (“Options”), nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs)”, and stock bonus awards. As of March 31, 2022, the Company had 21,086,366 shares of common stock reserved for future issuance of equity awards to employees, officers, directors, or consultants under the 2021 Plan. Pursuant to the terms of the Agreement and Plan of Merger, at the Closing of the Merger on March 8, 2021, the Company granted 12,500,000 Officer RSUs for shares of Class A Common Stock of the Company and 5,000,000 options to purchase Class A Common Stock of the Company (“Officer Options”) to View’s executive officers. The Officer RSUs are subject to both time and market-based vesting conditions. The Officer RSUs time vest over a four-year period with 25% to vest on the twelve-month anniversary of the Closing and the remaining 75% to vest on a monthly basis over the following thirty-six months subject to the following market-based vesting. 50% of the Officer RSUs granted to each executive officer will only vest if the share price hurdle of $15.00 is achieved and the remaining 50% of such Officer RSUs will vest if the share price hurdle of $20.00 is achieved. The Officer Options time vest over a four-year period with 25% to vest on the twelve-month anniversary of the Closing and the remaining 75% will vest on a monthly basis over the following thirty-six months. CEO Incentive Plan In connection with the Closing of the Merger, the Company adopted the 2021 Chief Executive Officer Incentive Plan (the “CEO Incentive Plan”) effective March 8, 2021. Pursuant to the CEO Incentive Plan and the terms of the Agreement and Plan of Merger, on March 8, 2021, the Company granted the CEO an option award to purchase Class A common stock of the Company at an exercise price of $10.00 per share, which vests and becomes exercisable upon satisfaction of the performance conditions set forth in the table below, contingent upon the CEO’s continued employment with the Company on each such vesting date. Tranche Option Shares (#) Average 60-day 1 2,500,000 $ 20.00 2 2,500,000 30.00 3 2,500,000 40.00 4 2,500,000 50.00 5 2,500,000 60.00 6 2,500,000 70.00 7 2,500,000 80.00 8 2,500,000 90.00 9 2,500,000 100.00 10 2,500,000 $ 110.00 The following table summarizes the activity under the 2021 Plan (in thousands, except per share data and contractual term) for time vested options: Options Outstanding Number of Weighted- Weighted-Average Aggregate Intrinsic Value 1 Balance as of December 31, 2021 27,582 $ 9.43 7.0 $ — Granted — — Exercised — — Canceled/forfeited (1,680) 9.37 Outstanding as of March 31, 2022 25,902 $ 9.44 6.7 $ — Options vested and expected to vest as of March 31, 2022 19,937 $ 9.44 6.4 $ — Exercisable as of March 31, 2022 25,670 $ 9.44 6.7 $ — _______________________ 1 The aggregate intrinsic value is calculated as the difference between the market value of the Company's common shares as of the relevant period end and the respective exercise prices of the options. The market value as of March 31, 2022 and December 31, 2021 was $1.84 and $3.91 per share, respectively, which is the closing sale price of View's common shares on that day as reported by the Nasdaq Global Market. No options have been issued or exercised under this plan in the three months ended March 31, 2022. The weighted-average grant date fair value per share of stock options granted was $4.38 for the three months ended March 31, 2021. The total grant date fair value of stock options vested was $6.4 million during the three months ended March 31, 2021. The total intrinsic value of options exercised during the three months ended March 31, 2021 was $0.4 million. As of March 31, 2022, total unrecognized compensation cost related to unvested stock options, net of estimated forfeitures, was $24.1 million and is expected to be recognized over a weighted-average remaining service period of 1.7 years. In addition to the time vested options above, as of March 31, 2022, total outstanding stock options under the CEO Incentive Plan was 25,000,000 shares which were issued during the three months ended March 31, 2021 with a grant date exercise price per share of $10.00 and remaining contractual term of 8.9 years. As of March 31, 2022, the CEO Option Award had no intrinsic value. The weighted-average grant date fair value per share of stock options granted under the CEO Incentive Plan was $3.54 for the three months ended March 31, 2021. As of March 31, 2022, total unrecognized compensation cost related to options under the CEO Incentive plan, net of estimated forfeitures, was $68.5 million and is expected to be recognized over a weighted-average remaining service period of 4.2 years. The following table summarizes the activities for our outstanding RSUs under the Company’s 2021 Plan (in thousands, except per share data) during the three months ended March 31, 2022: Number of Weighted Outstanding as of December 31, 2021 11,643 $ 6.14 Granted — — Vested (26) 7.58 Canceled (811) $ 6.28 Outstanding as of March 31, 2022 10,806 $ 6.13 The total grant date fair value of RSUs vested was $0.2 million during the three months ended March 31, 2022. As of March 31, 2022, total unrecognized compensation cost related to RSUs, net of estimated forfeitures, was $30.8 million and is expected to be recognized over a weighted-average remaining service period of 1.6 years. To the extent that the actual forfeiture rate is different than what the Company has anticipated, stock-based compensation related to these awards will be different from expectations. Valuation No options have been issued under this plan in the three months ended March 31, 2022. The estimated grant date fair values of the Company’s time vested stock options granted to employees and non-employees under the plan in the three months ended March 31, 2021 were calculated using the Black-Scholes option-pricing models based on the following assumptions: Three Months Ended March 31, 2021 Expected volatility 53.0% Expected terms (in years) 6.0 Expected dividends 0% Risk-free rate 1.07% Prior to the Merger, due to the absence of a public market, the Company’s common stock required the Company’s board of directors to estimate the fair value of its common stock for purposes of granting options and for determining stock-based compensation expense by considering several objective and subjective factors, including contemporaneous third-party valuations, actual and forecasted operating and financial results, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, the rights and preferences of redeemable convertible preferred stock and common, and transactions involving the Company’s stock. The fair value of the Company’s common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants guide, Valuation of Privately Held Company Equity Securities Issued as Compensation. The estimated grant date fair value for each tranche of CEO Option Award and Officer RSUs is determined by using the Monte Carlo Simulation valuation model and the assumptions below. The estimated grant date fair value of the Officer Options is determined using the Black-Scholes option-pricing model. The valuation models incorporated the following key assumptions: CEO Option Officer RSUs Officer Options Expected stock price $9.19 $9.19 $9.19 Expected volatility 54.0% 56.0% 53.0% Risk-free rate 1.59% 0.60% 1.07% Expected terms (in years) 10.0 4.0 6.0 Expected dividends 0% 0% 0% Discount for lack of marketability 20% n/a n/a Stock-based Compensation Expense The Company’s stock-based compensation included in its condensed consolidated statements of comprehensive loss was as follows (in thousands): Three Months Ended March 31, 2022 2021 Cost of revenue $ 363 $ 879 Research and development 69 914 Selling, general, and administrative 17,036 8,670 Total $ 17,468 $ 10,463

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company calculates the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to ordinary income or loss for the interim reporting period. When applicable, the year-to-date tax provision reflects adjustments from discrete tax items. For the three months ended March 31, 2022 and 2021, the Company’s income tax expense was immaterial. As our U.S. operations are projecting to be in a taxable loss in the year and based on all available objectively verifiable evidence during the three months ended March 31, 2022, the Company believes it is more likely than not that the tax benefits of the U.S. losses incurred will not be realized. Accordingly, the Company will continue to maintain a full valuation allowance on the U.S. deferred tax assets. The Company’s income tax expense for the three months ended March 31, 2022 is due primarily to income taxes in Canada. The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. During the three months ended March 31, 2022, there have been no changes in the estimated uncertain tax benefits.

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended March 31, 2022 2021 Net loss $ (82,372) $ (74,035) Weighted-average shares outstanding, basic and diluted 214,232,210 55,500,398 Net loss per share, basic and diluted $ (0.38) $ (1.33) As a result of the Merger, the weighted-average number of shares of common stock used in the calculation of net loss per share have also been retroactively converted by applying the Exchange Ratio. For the three months ended March 31, 2022, common stock equivalents consisted of stock options, restricted stock units and warrants. For the three months ended March 31, 2021, common stock equivalents consisted of stock options and warrants. None of the common stock equivalents were included in the calculation of diluted net loss per share for all periods presented as the Company recorded a net loss. The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect: March 31, 2022 2021 Stock options to purchase common stock 25,901,653 29,630,036 Unvested restricted stock units 5,625 — Warrants to purchase common stock 21,311,920 20,428,170 Total 47,219,198 50,058,206

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that no additional material subsequent events exist other than the environmental matter disclosed in Note 7 .

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization View, Inc. (f/k/a CF Finance Acquisition Corp. II) and its wholly-owned subsidiaries (collectively “View” or the “Company”) headquartered in Milpitas, California, is a technology company that manufactures smart building products intended to help improve people’s health, productivity and experience, while simultaneously reducing energy consumption. View’s primary product is a proprietary electrochromic or “smart” glass panel that when combined with View’s proprietary network infrastructure and software, intelligently adjusts in response to the sun by tinting from clear to dark states, and vice versa thereby reducing heat and glare. The Company is devoting substantially all of its efforts towards the manufacturing, sale and further development of its product platforms, and marketing of both custom and standardized product solutions.
Basis of Presentation	Basis of Presentation The condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting and are unaudited. The Company’s condensed consolidated financial statements include the accounts of View, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on December 31. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021, included in the Company’s 2021 Annual Report on Form 10-K filed with the SEC on June 15, 2022 (the “2021 Annual Report on Form 10-K”). The information as of December 31, 2021 included in the condensed consolidated balance sheets was derived from those audited consolidated financial statements. As a result of the Transactions completed on March 8, 2021, prior period share and per share amounts presented in the accompanying condensed consolidated financial statements and these related notes have been retroactively converted in an amount determined by application of the exchange ratio of 0.02325 (“Exchange Ratio”), which was based on Legacy View’s implied price per share prior to the Merger. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and included herein reflect all adjustments, including normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of March 31, 2022, and the results of operations and cash flows for the three months ended March 31, 2022. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the full year or any other future interim or annual periods. All amounts are presented in U.S. dollars ($).
Concentration of Credit Risk and Other Risks and Uncertainties	Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are held by domestic financial institutions with high credit standings. Such deposits may, at times, exceed federally insured limits. As of March 31, 2022, the Company has not experienced any losses on its deposits of cash and cash equivalents. For the three months ended March 31, 2022, three customers represented greater than 10.0% of total revenue, each accounting for 18.0%, 15.7% and 10.8% of total revenue. For the three months ended March 31, 2021, two customers represented greater than 10.0% of total revenue, each accounting for 31.8% and 10.3% of total revenue. Two customers accounted for 34.6% of accounts receivable, net as of March 31, 2022, including 17.9% and 16.7%, respectively. Four customers accounted for 53.0% of accounts receivable, net as of December 31, 2021, including 15.2%, 13.3%, 12.8% and 11.8%, respectively. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. Certain materials used by the Company in the manufacturing of its products are purchased from a limited number of suppliers. Shortages could occur in these materials due to an interruption of supply or increased demand in the industry. For the three months ended March 31, 2022, three suppliers accounted for 31.3%, 16.7% and 13.8% of total purchases. For the three months ended March 31, 2021, two suppliers accounted for 37.3% and 12.7% of total purchases.
Segment Reporting	Segment Reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company operates and manages its business as one reportable and operating segment. The Company’s chief executive officer, who is the chief operating decision maker, reviews financial information on a consolidated basis for purposes of allocating resources and assessing performance. All material long-lived assets are maintained in the United States. See “Concentration of Credit Risk and Other Risks and Uncertainties” for further information on revenue by customer and Note 3 for further information on revenue by geography and categorized by products and services.
Recent Accounting Pronouncements Adopted and Recent Accounting Pronouncements, Not Yet Adopted	Recent Accounting Pronouncements, Adopted In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt — Modifications and Extinguishments (Subtopic 470-50), Compensation — Stock Compensation (Topic 718), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (“ASU No. 2021-04”). This ASU provides a principles-based framework for issuers to account for a modification or exchange of freestanding equity-classified written call options that remain equity classified after the modification or exchange based on the economic substance of the modification or exchange. The Company has adopted this standard as of the first quarter of 2022 and the adoption did not have an impact on the condensed consolidated financial statements. Recent Accounting Pronouncements, Not Yet Adopted In August 2020, the FASB issued No. ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”) . This ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (“EPS”) calculation in certain areas. ASU 2020-6 is effective for fiscal years beginning after December 15, 2023 including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating whether this guidance will have a significant impact on its condensed consolidated financial statements.
Revenue Recognition	Disaggregation of Revenue The Company disaggregates revenue between products and services, as well as by major product offering and by geographic market that depict the nature, amount, and timing of revenue and cash flows. Remaining Performance Obligations The Company’s IGU contracts are short-term in nature and the practical expedient has been applied. The Company’s performance obligations in CSS contracts are generally short-term in nature, for which the practical expedient has been applied, with the exception of commissioning services, which are provided at the end of a construction project. Revenue for commissioning services performance obligations is not material. The Company’s performance obligations in Smart Building Platform contracts are longer-term in nature, however many of these contracts provide the customer with a right to cancel or terminate for convenience with no substantial penalty. The transaction price allocated to remaining performance obligations for non-cancelable Smart Building Platform contracts as of March 31, 2022 was $7.9 million that the Company expects to recognize as it satisfies the performance obligations over the next 12 to 24 months which are, among other things, dependent on the construction schedule of the site for which the Company's products and services are provided. The Company’s performance obligations in Smart Building Technologies contracts are generally short-term in nature, for which the practical expedient has been applied. Contract Assets and Liabilities Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing, where payment is conditional, as well as retainage for amounts that we have billed to the customer but are being held for payment by the customer pending satisfactory completion of the project. Current contract assets as of March 31, 2022 and December 31, 2021 were $12.5 million and $11.5 million, respectively, and were included in other current assets. The increase in 2021 primarily relates to contract assets associated with View Smart Building Platform contracts, which commenced in 2021. The progress billing schedules for these contracts result in timing differences as compared to the Company’s satisfaction of its performance obligation. Non-current contract assets as of March 31, 2022 and December 31, 2021 were $0.7 million and $0.7 million, respectively, and were included in other assets. Contract liabilities relate to amounts invoiced or consideration received from customers, typically for the Company’s CSS contracts, in advance of the Company’s satisfaction of the associated performance obligation. Such contract liabilities are recognized as revenue when the performance obligation is satisfied. Contract liabilities are presented as deferred revenue on the condensed consolidated balance sheets.
Fair Value Measurement of Financial Assets and Liabilities	Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be either recorded or disclosed at fair value, the Company considers the principal or most advantageous market in which it would transact, and it also considers assumptions that market participants would use when pricing the asset or liability. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. U.S. GAAP establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: Level 1 Observable inputs such as quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 Inputs other than the quoted prices in active markets that are observable either directly or indirectly. Level 3 Unobservable inputs in which there are little or no market data and which require the Company to develop its own assumptions. At Closing, the Sponsor subjected 4,970,000 shares (“Sponsor Earn-Out Shares”) to vesting and potential forfeiture (and related transfer restrictions) based on a five year post-Closing earnout, with (a) 50% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $12.50 for 5 out of any 10 trading days, (b) 25% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $15.00 for 5 out of any 10 trading days and (c) 25% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $20.00 for 5 out of any 10 trading days, in each case, subject to early release for a sale, change of control or going private transaction or delisting after the Closing (collectively, the “Earn-Out Triggering Events”). These Sponsor Earn-Out Shares are accounted for as liability classified instruments because the Earn-Out Triggering Events that determine the number of Sponsor Earn-Out Shares to be earned back by the Sponsor include events that are not solely indexed to the common stock of the Company. As of March 31, 2022, the Earn-Out Triggering Events were not achieved for any of the tranches and as such the Company adjusted the carrying amount of the liability to its estimated fair value. Sponsor Earn-out Shares, Private Warrants and redeemable convertible preferred stock warrants are or were subject to remeasurement to fair value at each balance sheet date. See Note 2
Product Warranties	The Company provides a standard assurance type warranty that its insulating glass units (“IGUs”) will be free from defects in materials and workmanship for generally 10 years from the date of delivery to customers. IGUs with sloped or laminated glass generally have a warranty of 5 or 10 years. Control systems associated with the sale of Controls, Software and Services (“CSS”) typically have a 5-year warranty. As part of the Company’s Smart Building Platform contracts, the Company generally warrants that the workmanship of the sub-assemblies and installation of the Smart Building Platform are free from defects and in conformance with the contract documents for one year from completion. In resolving warranty claims, the Company’s standard warranty terms provide that the Company generally has the option of repairing, replacing or refunding the selling price of the covered product. The Company has not been requested to and has not provided any refunds, which would be treated as a reduction to revenue, as of March 31, 2022. The Company accrues for estimated claims of defective products at the time revenue is recognized based on historical warranty claims rates. The Company’s estimated costs for standard warranty claims are based on future estimated costs the Company expects to incur to replace the IGUs or control systems multiplied by the estimated IGU or control system warranty claims, respectively, based on warranty contractual terms and business practices. The total warranty liability included $6.0 million and $6.1 million as of March 31, 2022 and December 31, 2021, respectively, related to this standard assurance warranty. In 2019, the Company identified a quality issue with certain material purchased from one of its suppliers utilized in the manufacturing of certain IGUs. The Company stopped using the affected materials upon identification of the quality issue in 2019. The Company has replaced and expects to continue to replace the affected IGUs for the remainder of the period covered by the warranty. The Company developed a statistical model to analyze the risk of failure of the affected IGUs related to this quality issue and predict the potential number of future failures that may occur during the remaining warranty period, as well as the timing of the expected failures. Management judgment is necessary to determine the distribution fit and covariates utilized in the statistical model, as well as the relative tolerance to declare convergence. The statistical model considered the volume of units sold, the volume of unit failures, data patterns, and other characteristics associated with the failed IGUs as well as the IGUs that had not yet failed as of each financial reporting period. These characteristics include, but are not limited to, time to failure, manufacture date, location of installation, and environmental factors. Based on this analysis, the Company has recorded a specific warranty liability using the estimated number of affected IGUs expected to fail in the remaining warranty period and applying estimated costs the Company expects to incur to replace the IGUs based on warranty contractual terms and business practices. The total warranty liability included $34.9 million and $36.2 million as of March 31, 2022 and December 31, 2021, respectively, related to these IGUs. The Company monitors warranty obligations and may make adjustments to its warranty liabilities if actual costs of product repair and replacement are significantly higher or lower than estimated. Accruals for anticipated future warranty costs are recorded to cost of revenue in the condensed consolidated statements of comprehensive loss and included in other current liabilities and other liabilities on the condensed consolidated balance sheet. Warranty liabilities are based on estimates of failure rates and future costs to settle warranty claims that are updated periodically, taking into consideration inputs such as changes in the volume of claims compared with the Company’s historical experience, and changes in the cost of servicing warranty claims. The estimated cost includes the Company’s expectations regarding future total cost of replacement, as well as fixed cost absorption as production increases. The Company accounts for the effect of changes in estimates prospectively.

Reverse Recapitalization (Table

Reverse Recapitalization (Tables)	3 Months Ended
	Mar. 31, 2022
Reverse Recapitalization [Abstract]
Schedule Of Reverse Recapitalization	The number of shares of Class A common stock issued immediately following the consummation of the Merger on March 8, 2021 was: Number of Shares Common stock of CF II outstanding prior to the Merger 1 62,500,000 Less redemption of CF II shares (12,587,893) CF II Sponsor Earnout Shares outstanding prior to the Merger 1,100,000 Common stock of CF II 51,012,107 Shares issued in PIPE financing 42,103,156 Shares issued for in kind banker fee payment 750,000 Merger and PIPE financing shares 42,853,156 Legacy View shares converted 2 123,211,449 Total 217,076,712 1 Includes CF II Class A shareholders of 50,000,000 and CF II Class B shareholders of 12,500,000.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Summary of Company's Revenue	The following table summarizes the Company’s revenue by products and services (in thousands): Three Months Ended March 31, 2022 2021 Revenue: Products $ 15,533 $ 9,711 Services 1,479 58 Total $ 17,012 $ 9,769 The following table summarizes the Company's revenue by major product offering (in thousands): Three Months Ended March 31, 2022 2021 Revenue: Smart Glass $ 5,183 $ 8,215 Smart Building Platform 9,206 — Smart Building Technologies 2,623 1,554 Total $ 17,012 $ 9,769 The following table summarizes the Company’s revenue by geographic area, which is based on the shipping address of the customers (in thousands): Three Months Ended March 31, 2022 2021 Revenue: United States $ 16,284 $ 9,665 Canada 718 104 Other 10 — Total $ 17,012 $ 9,769

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Summary of Fair Value Measurements	The following table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands): March 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 167,522 $ — $ — $ 167,522 Total cash equivalents 167,522 — — 167,522 Restricted cash: Certificates of deposit 16,466 — 16,466 Total assets measured at fair value $ 167,522 $ 16,466 $ — $ 183,988 Sponsor earn-out liability — — 3,331 3,331 Private warrants liability $ — $ — $ 86 $ 86 Total liabilities measured at fair value $ — $ — $ 3,417 $ 3,417 December 31, 2021 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 247,500 $ — $ — $ 247,500 Total cash equivalents 247,500 — — 247,500 Restricted cash: Certificates of deposit — 16,462 — 16,462 Total assets measured at fair value $ 247,500 $ 16,462 $ — $ 263,962 Sponsor earn-out liability $ — $ — $ 7,624 $ 7,624 Private warrants liability $ 174 174 Total liabilities measured at fair value $ — $ — $ 7,798 $ 7,798
Summary of Level 3 Financial Liabilities Measured at Fair Value Using Significant Unobservable Inputs	The following table provides a reconciliation of the beginning and ending balances for the level 3 financial liabilities measured at fair value using significant unobservable inputs (in thousands): Sponsor Private Balance as of December 31, 2021 $ 7,624 $ 174 Change in fair value 4,293 88 Balance as of March 31, 2022 $ 11,917 $ 262
Summary of Gain (Loss) in Fair Value	The following table summarizes the (gain) loss on fair value change, net (in thousands): Three Months Ended March 31, 2022 2021 Sponsor Earn-out Liability $ (4,293) $ (2,460) Private Warrants (88) 103 Redeemable Convertible Preferred Stock Warrants — (5,056) Gain on fair value change, net $ (4,381) $ (7,413)
Summary of Assumptions Used in Determination of Fair Value of Derivatives	The estimated fair value of the Sponsor Earn-Out Shares was determined using a Monte Carlo simulation valuation model using the following assumptions: March 31, 2022 December 31, 2021 Stock price $1.84 $3.91 Expected volatility 73.25% 52.50% Risk free rate 2.44% 1.12% Expected term (in years) 3.9 4.2 Expected dividends 0% 0% The estimated fair value of the Private Warrants was determined using the Black-Scholes option-pricing model using the following assumptions: March 31, 2022 December 31, 2021 Stock price $1.84 $3.91 Expected volatility 73.30% 52.50% Risk free rate 2.44% 1.04% Expected term (in years) 3.4 3.7 Expected dividends 0% 0%

Other Balance Sheet Informati_2

Other Balance Sheet Information (Tables)	3 Months Ended
	Mar. 31, 2022
Payables and Accruals [Abstract]
Restrictions on Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): March 31, 2022 December 31, 2021 Cash $ 33,010 $ 33,581 Cash equivalents 167,522 247,500 Cash and cash equivalents 200,532 281,081 Restricted cash 16,466 16,462 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 216,998 $ 297,543
Schedule of Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): March 31, 2022 December 31, 2021 Cash $ 33,010 $ 33,581 Cash equivalents 167,522 247,500 Cash and cash equivalents 200,532 281,081 Restricted cash 16,466 16,462 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 216,998 $ 297,543

Product Warranties (Tables)

Product Warranties (Tables)	3 Months Ended
	Mar. 31, 2022
Guarantees and Product Warranties [Abstract]
Schedule of Product Warranty Liability	Changes in warranty liabilities are presented below (in thousands): March 31, 2022 December 31, 2021 Beginning balance $ 42,256 $ 47,678 Accruals for warranties issued 618 1,551 Changes to estimates of volume and costs — 1,234 Settlements made (1,918) (8,207) Ending balance $ 40,956 $ 42,256 Warranty liability, current, beginning balance $ 8,868 $ 8,864 Warranty liability, noncurrent, beginning balance $ 33,388 $ 38,814 Warranty liability, current, ending balance $ 8,987 $ 8,868 Warranty liability, noncurrent, ending balance $ 31,969 $ 33,388

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Litigation Settlement Liability	The balance of the litigation settlement liability is reflected on our condensed consolidated balance sheets as follows (in thousands): March 31, December 31, 2021 Litigation settlement liability - current $ 3,000 $ — Litigation settlement liability - non-current 5,082 7,834 Total litigation settlement liability $ 8,082 $ 7,834 The balance of the environmental settlement liability is reflected on our condensed consolidated balance sheets as follows (in thousands): March 31, December 31, 2021 Environmental settlement liability - current $ 2,950 $ 2,950 Environmental settlement liability - non-current 2,000 2,000 Total environmental settlement liability $ 4,950 $ 4,950

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Summary of Debt	Debt outstanding consisted of the following (in thousands): Interest Rate March 31, December 31, 2021 Term loan, due June 30, 2032 0% $ 15,430 $ 15,430 Total debt 15,430 15,430 Debt, current 1,470 1,470 Debt, non-current $ 13,960 $ 13,960
Schedule of Estimated Principal Payments on all Debt Oustanding	Principal payments on all debt outstanding as of March 31, 2022 are estimated as follows (in thousands): Year Ending December 31, Total 2022 (remaining nine months) $ 1,470 2023 1,470 2024 1,470 2025 1,470 2026 1,470 Thereafter 8,080 Total $ 15,430

Stock Warrants (Tables)

Stock Warrants (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Summary of Outstanding Common Stock Warrants	The following table summarizes the outstanding common stock warrants: Warrant issue date Types of shares Number of Warrants Number of Warrants December 31, 2021 (As converted) Exercise Expiry Date August 2010 - June 2011 Common stock (previously Series B redeemable convertible preferred stock) 46,498 46,498 $ 15.49 March 2023 August 2011 - January 2012 Common stock (previously Series C redeemable convertible preferred stock) 53,256 53,256 18.78 March 2023 August 2012 Common stock (previously Series D redeemable convertible preferred stock) 45,388 45,388 21.60 March 2023 December 2013 Common stock (previously Series E redeemable convertible preferred stock) 63,296 63,296 25.91 March 2023 April 2015 - April 2016 Common stock (previously Series F redeemable convertible preferred stock) 45,207 45,207 38.71 Through December 2022 April 2016 - November 2018 Common stock (previously Series H redeemable convertible preferred stock) 1,135,391 1,135,391 18.93 Through November 2028 March 2017 Common stock (previously Series H redeemable convertible preferred stock) 1,849,431 1,849,431 12.91 March 2027 March 2014 Common stock 2,324 2,324 9.47 August 2023 August 2015 Common stock 12,916 12,916 11.62 December 2022 December 2018 Common stock 24,910 24,910 9.04 December 2028 August 2020 Common stock (Private Warrants) 366,666 366,666 11.50 Through March 2026 August 2020 Common stock (Public Warrants) 16,666,637 16,666,637 11.50 Through March 2026 December 2021 Common stock (in connection with the WorxWell acquisition) 1,000,000 1,000,000 $ 10.00 December 2031 Total stock warrants 21,311,920 21,311,920

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Summary of Stock Options Exercisable under CEO Incentive Plan	Tranche Option Shares (#) Average 60-day 1 2,500,000 $ 20.00 2 2,500,000 30.00 3 2,500,000 40.00 4 2,500,000 50.00 5 2,500,000 60.00 6 2,500,000 70.00 7 2,500,000 80.00 8 2,500,000 90.00 9 2,500,000 100.00 10 2,500,000 $ 110.00
Summary of Share-based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable	The following table summarizes the activity under the 2021 Plan (in thousands, except per share data and contractual term) for time vested options: Options Outstanding Number of Weighted- Weighted-Average Aggregate Intrinsic Value 1 Balance as of December 31, 2021 27,582 $ 9.43 7.0 $ — Granted — — Exercised — — Canceled/forfeited (1,680) 9.37 Outstanding as of March 31, 2022 25,902 $ 9.44 6.7 $ — Options vested and expected to vest as of March 31, 2022 19,937 $ 9.44 6.4 $ — Exercisable as of March 31, 2022 25,670 $ 9.44 6.7 $ — _______________________
Summary of Outstanding Restricted Stock Units	The following table summarizes the activities for our outstanding RSUs under the Company’s 2021 Plan (in thousands, except per share data) during the three months ended March 31, 2022: Number of Weighted Outstanding as of December 31, 2021 11,643 $ 6.14 Granted — — Vested (26) 7.58 Canceled (811) $ 6.28 Outstanding as of March 31, 2022 10,806 $ 6.13
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The estimated grant date fair values of the Company’s time vested stock options granted to employees and non-employees under the plan in the three months ended March 31, 2021 were calculated using the Black-Scholes option-pricing models based on the following assumptions: Three Months Ended March 31, 2021 Expected volatility 53.0% Expected terms (in years) 6.0 Expected dividends 0% Risk-free rate 1.07% The estimated grant date fair value for each tranche of CEO Option Award and Officer RSUs is determined by using the Monte Carlo Simulation valuation model and the assumptions below. The estimated grant date fair value of the Officer Options is determined using the Black-Scholes option-pricing model. The valuation models incorporated the following key assumptions: CEO Option Officer RSUs Officer Options Expected stock price $9.19 $9.19 $9.19 Expected volatility 54.0% 56.0% 53.0% Risk-free rate 1.59% 0.60% 1.07% Expected terms (in years) 10.0 4.0 6.0 Expected dividends 0% 0% 0% Discount for lack of marketability 20% n/a n/a
Summary of Stock-based Compensation	The Company’s stock-based compensation included in its condensed consolidated statements of comprehensive loss was as follows (in thousands): Three Months Ended March 31, 2022 2021 Cost of revenue $ 363 $ 879 Research and development 69 914 Selling, general, and administrative 17,036 8,670 Total $ 17,468 $ 10,463

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Summary of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended March 31, 2022 2021 Net loss $ (82,372) $ (74,035) Weighted-average shares outstanding, basic and diluted 214,232,210 55,500,398 Net loss per share, basic and diluted $ (0.38) $ (1.33)
Summary of Antidilutive Securities Excluded From Computation of Earnings Per Share	The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect: March 31, 2022 2021 Stock options to purchase common stock 25,901,653 29,630,036 Unvested restricted stock units 5,625 — Warrants to purchase common stock 21,311,920 20,428,170 Total 47,219,198 50,058,206

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies - Organization (Details) $ in Millions	Mar. 08, 2021 USD ($)
Product Information [Line Items]
Charges associated with the mergers	$ 43.9
Common Class A
Product Information [Line Items]
Share exchange ratio	0.02325
Principal And Interest
Product Information [Line Items]
Repayments of other debt obligations	$ 276.8
Interest
Product Information [Line Items]
Repayments of other debt obligations	26.8
Reverse Recapitalization
Product Information [Line Items]
Net proceeds	771.3
Charges associated with the mergers	$ 43.9

Organization and Summary of S_4

Organization and Summary of Significant Accounting Policies - Liquidity and Going Concern (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Product Information [Line Items]
Total stockholders’ deficit	$ (414,434)	$ (677,942)	$ (479,338)	$ 1,824,564
Net loss	82,372	74,035
Negative cash flows from operations	71,274	70,338
Cash and cash equivalents	200,532		281,081
Accumulated Deficit
Product Information [Line Items]
Total stockholders’ deficit	2,339,703	1,988,388	$ 2,257,331	$ 1,914,353
Net loss	$ 82,372	$ 74,035

Organization and Summary of S_5

Organization and Summary of Significant Accounting Policies - Concentration Risk (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Revenue Benchmark | Supplier Concentration Risk | Supplier One
Concentration Risk [Line Items]
Concentration risk percentage	31.30%	37.30%
Revenue Benchmark | Supplier Concentration Risk | Supplier Two
Concentration Risk [Line Items]
Concentration risk percentage	16.70%	12.70%
Revenue Benchmark | Supplier Concentration Risk | Supplier Three
Concentration Risk [Line Items]
Concentration risk percentage	13.80%
Customer One | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	18%	31.80%
Customer One | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	17.90%		15.20%
Customer Two | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	15.70%	10.30%
Customer Two | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	16.70%		13.30%
Customer Three | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	10.80%
Customer Three | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			12.80%
Two Customers | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	34.60%
Four Customers | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			53%
Customer Four | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			11.80%

Organization and Summary of S_6

Organization and Summary of Significant Accounting Policies - Segment Reporting (Details)	3 Months Ended
	Mar. 31, 2022 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	1
Number of operating segments	1

Reverse Recapitalization - Addi

Reverse Recapitalization - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Mar. 08, 2021	Mar. 31, 2022	Mar. 31, 2021
Class of Stock [Line Items]
Proceeds from reverse recapitalization	$ 815,200	$ 0	$ 815,184
Recapitalization exchange, price per share (in dollars per share)	$ 10
Charges associated with the mergers	$ 43,900
Payment for merger related costs, expensed immediately	1,500
Additional Paid-In Capital
Class of Stock [Line Items]
Stock issuance costs recorded in APIC	42,400
Common Class A
Class of Stock [Line Items]
Proceeds from common stock issue net of redemption	374,100
Redemption of CFII common stock	125,900
Proceeds from private investment in public equity	$ 260,800
Sale of stock issue price per share (in dollars per share)	$ 10
Proceeds from additional private investment in public equity	$ 180,300
Sale of additional stock issue price per share (in dollars per share)	$ 11.25

Reverse Recapitalization - Sche

Reverse Recapitalization - Schedule of Reverse Recapitalization (Details) - shares	Mar. 08, 2021	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Mar. 07, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Common stock, share outstanding (in shares)	217,076,712	219,222,346	219,195,971		76,565,107
CF II Sponsor Earnout Shares outstanding prior to the Merger (in shares)	1,100,000
Shares issued in PIPE financing (in shares)	42,103,156
Shares issued for in kind banker fee payment (in shares)	750,000
Merger and PIPE financing shares (in shares)	42,853,156
Legacy View shares converted (in shares)	123,211,449
Redeemable convertible preferred stock shares outstanding (in shares)				0	5,222,852,052	121,431,000
CF II
Class of Stock [Line Items]
Common stock, share outstanding (in shares)	51,012,107				62,500,000
Less redemption of CF II shares (in shares)	(12,587,893)
CF II | Common Class A
Class of Stock [Line Items]
Common stock, share outstanding (in shares)					50,000,000
CF II | Common Class B
Class of Stock [Line Items]
Common stock, share outstanding (in shares)					12,500,000

Revenue - Summary of Company's

Revenue - Summary of Company's Revenue by Products and Services (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 17,012	$ 9,769
Products
Disaggregation of Revenue [Line Items]
Revenue	15,533	9,711
Services
Disaggregation of Revenue [Line Items]
Revenue	1,479	58
Smart Glass
Disaggregation of Revenue [Line Items]
Revenue	5,183	8,215
Smart Building Platform
Disaggregation of Revenue [Line Items]
Revenue	9,206	0
Smart Building Technologies
Disaggregation of Revenue [Line Items]
Revenue	$ 2,623	$ 1,554

Revenue - Additional Informatio

Revenue - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Contract loss accrual	$ 2,500	$ 2,100
Contract loss accrual recognized	4,000
Catch-up adjustment to revenue	900	$ 0
Contract losses for work not completed	18,300		$ 20,700
Current contract assets	12,500		11,500
Noncurrent contract assets	700		$ 700
Contract with customer liability revenue recognized	2,300
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Disaggregation of Revenue [Line Items]
Transaction price allocated to remaining performance obligation	$ 7,900
Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Disaggregation of Revenue [Line Items]
Revenue recognize period	12 months
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Disaggregation of Revenue [Line Items]
Revenue recognize period	24 months

Revenue - Summary of Company'_2

Revenue - Summary of Company's Revenue by Geographic Area (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 17,012	$ 9,769
United States
Disaggregation of Revenue [Line Items]
Revenue	16,284	9,665
Canada
Disaggregation of Revenue [Line Items]
Revenue	718	104
Other
Disaggregation of Revenue [Line Items]
Revenue	$ 10	$ 0

Fair Value - Additional Informa

Fair Value - Additional Information (Detail)	Mar. 08, 2021 $ / shares shares	Mar. 31, 2022 $ / shares shares	Dec. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out shares subject to vesting and potential forfeiture | shares	4,970,000	4,970,000
Earnout shares period of vesting	5 years
Share price (in dollars per share)		$ 1.84
Earnout Triggering Event One
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Percentage of the earnout shares releasable	50%
Share price (in dollars per share)	$ 12.50
Number of trading days	5 days
Number of consecutive trading days	10 days
Earnout Triggering Event Two
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Percentage of the earnout shares releasable	25%
Share price (in dollars per share)	$ 15
Number of trading days	5 days
Number of consecutive trading days	10 days
Earnout Triggering Event Three
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Percentage of the earnout shares releasable	25%
Share price (in dollars per share)	$ 20
Number of trading days	5 days
Number of consecutive trading days	10 days
Expected dividends | Sponsor Earn-out Liability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0	0

Fair Value - Summary of Fair Va

Fair Value - Summary of Fair Value Measurements (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Cash equivalents:
Cash equivalents	$ 167,522	$ 247,500
Restricted cash:
Certificates of deposit	16,466	16,462
Total assets measured at fair value	183,988	263,962
Sponsor earn-out liability	3,331	7,624
Private warrants liability	86	174
Total liabilities measured at fair value	3,417	7,798
Money market funds
Cash equivalents:
Cash equivalents	167,522	247,500
Level 1
Cash equivalents:
Cash equivalents	167,522	247,500
Restricted cash:
Certificates of deposit		0
Total assets measured at fair value	167,522	247,500
Sponsor earn-out liability	0	0
Private warrants liability	0
Total liabilities measured at fair value	0	0
Level 1 | Money market funds
Cash equivalents:
Cash equivalents	167,522	247,500
Level 2
Cash equivalents:
Cash equivalents	0	0
Restricted cash:
Certificates of deposit	16,466	16,462
Total assets measured at fair value	16,466	16,462
Sponsor earn-out liability	0	0
Private warrants liability	0
Total liabilities measured at fair value	0	0
Level 2 | Money market funds
Cash equivalents:
Cash equivalents	0	0
Level 3
Cash equivalents:
Cash equivalents	0	0
Restricted cash:
Certificates of deposit	0	0
Total assets measured at fair value	0	0
Sponsor earn-out liability	3,331	7,624
Private warrants liability	86	174
Total liabilities measured at fair value	3,417	7,798
Level 3 | Money market funds
Cash equivalents:
Cash equivalents	$ 0	$ 0

Fair Value - Summary of level 3

Fair Value - Summary of level 3 financial liabilities measured at fair value using significant unobservable inputs (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($)
Sponsor Earn-out Liability
Summary of level 3 financial liabilities measured at fair value using significant unobservable inputs [Line Items]
Beginning balance	$ 7,624
Change in fair value	4,293
Ending balance	11,917
Private Warrants
Summary of level 3 financial liabilities measured at fair value using significant unobservable inputs [Line Items]
Beginning balance	174
Change in fair value	88
Ending balance	$ 262

Fair Value - Changes In Fair Va

Fair Value - Changes In Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain on fair value change, net	$ (4,381)	$ (7,413)
Sponsor Earn-out Liability
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain on fair value change, net	(4,293)	(2,460)
Private Warrants | Warrants to purchase common stock
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain on fair value change, net	(88)	103
Redeemable Convertible Preferred Stock Warrants | Warrants to purchase common stock
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain on fair value change, net	$ 0	$ (5,056)

Fair Value - Summary of Assumpt

Fair Value - Summary of Assumptions Used in Determination of Fair Value of Derivatives (Detail)	Mar. 31, 2022 yr	Dec. 31, 2021 yr
Sponsor Earn-out Liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.84	3.91
Sponsor Earn-out Liability | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.7325	0.5250
Sponsor Earn-out Liability | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0244	0.0112
Sponsor Earn-out Liability | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3.9	4.2
Sponsor Earn-out Liability | Expected dividends
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0
Private Warrants | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.84	3.91
Private Warrants | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.7330	0.5250
Private Warrants | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0244	0.0104
Private Warrants | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3.4	3.7
Private Warrants | Expected dividends
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0

Other Balance Sheet Informati_3

Other Balance Sheet Information - Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Cash and Cash Equivalents [Abstract]
Cash	$ 33,010	$ 33,581
Cash equivalents	167,522	247,500
Cash and cash equivalents	200,532	281,081
Restricted cash	16,466	16,462
Total cash, cash equivalents, and restricted cash presented in the statements of cash flows	$ 216,998	$ 297,543	$ 517,921	$ 74,693

Other Balance Sheet Informati_4

Other Balance Sheet Information - Additional Information (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2022 USD ($) acquisition	Mar. 31, 2021 USD ($)	Dec. 31, 2021 USD ($) acquisition
Payables and Accruals [Abstract]
Allowance for doubtful accounts	$ 700,000		$ 700,000
Inventory write-down	6,300,000	$ 500,000
Asset impairment charges	0	0
Impairment of goodwill and intangible assets	$ 0	$ 0
Number of Businesses Acquired | acquisition	0		2

Product Warranties - Additional

Product Warranties - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Product Warranty Liability [Line Items]
Warranty liability	$ 40,956		$ 42,256	$ 47,678
Cost of revenue
Product Warranty Liability [Line Items]
Charge to cost of revenues for adjustments to the warranty liability	600	$ 400
Accrued expenses and other current liabilities
Product Warranty Liability [Line Items]
Warranty liability	$ 34,900		36,200
IGU
Product Warranty Liability [Line Items]
Standard product warranty term	10 years
Warranty liability	$ 6,000		$ 6,100
IGUS With Sloped Or Laminated Glass | Minimum
Product Warranty Liability [Line Items]
Standard product warranty term	5 years
IGUS With Sloped Or Laminated Glass | Maximum
Product Warranty Liability [Line Items]
Standard product warranty term	10 years
Control System Associated With The Sale Of IGUS
Product Warranty Liability [Line Items]
Standard product warranty term	5 years

Product Warranties - Schedule o

Product Warranties - Schedule of Product Warranties (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance	$ 42,256	$ 47,678
Accruals for warranties issued	618	1,551
Changes to estimates of volume and costs	0	1,234
Settlements made	(1,918)	(8,207)
Ending balance	40,956	42,256
Warranty liability, current, beginning balance	8,987	8,868
Warranty liability, noncurrent, beginning balance	33,388	38,814
Warranty liability, current, ending balance	8,868	8,864
Warranty liability, noncurrent, ending balance	$ 31,969	$ 33,388

Commitments and Contingencies -

Commitments and Contingencies - Litigation Settlement Liability (Details) - USD ($)	1 Months Ended		3 Months Ended
	Jun. 30, 2021	Dec. 31, 2014	Mar. 31, 2022	Dec. 31, 2021
Other Commitments [Line Items]
Non-cancelable commitment to purchase certain license subscriptions	$ 10,000,000
Non-cancelable commitment to purchase certain license subscriptions, interest rate before maturity			0%
Non-cancelable commitment to purchase certain license subscriptions, interest rate after maturity			3.50%
Litigation settlement, payment made to third party		$ 32,000,000
Periodic payment term		10 years
Litigation settlement liability - current			$ 3,000,000	$ 0
Litigation settlement liability - non-current			5,082,000	7,834,000
Total litigation settlement liability			8,082,000	7,834,000
Environmental settlement liability - current			2,950,000	2,950,000
Environmental settlement liability - non-current			2,000,000	2,000,000
Total environmental settlement liability			4,950,000	4,950,000
Standby Letter of Credit
Other Commitments [Line Items]
Total value of letters of credit issued by bank			16,500,000	$ 16,500,000
Amounts drawn under standby letters of credit			0
Northern District of Mississippi Environmental Matter
Other Commitments [Line Items]
Litigation settlement, penalties incurred			$ 5,000,000
Litigation settlement, repayment period			3 years

Commitments and Contingencies_2

Commitments and Contingencies - Northern District of Mississippi Environmental Investigation (Details) - Northern District of Mississippi Environmental Matter - USD ($)		3 Months Ended
	Apr. 13, 2022	Mar. 31, 2022
Long-term Purchase Commitment [Line Items]
Litigation settlement, repayment period		3 years
Litigation settlement, penalties incurred		$ 5,000,000
Subsequent Event
Long-term Purchase Commitment [Line Items]
Agree to probation years	3 years
Environmental Management System Implementation | Subsequent Event
Long-term Purchase Commitment [Line Items]
Loss contingency, estimate of possible loss	$ 300,000
Wastewater Reduction Plan Implementation | Subsequent Event
Long-term Purchase Commitment [Line Items]
Loss contingency, estimate of possible loss	2,000,000
Federal Government | Subsequent Event
Long-term Purchase Commitment [Line Items]
Litigation settlement, amount due to third-party	$ 3,000,000
Litigation settlement, repayment period	3 years
Yearly installment amount	$ 1,000,000
Special assessment amount	125
Mississippi Commission On Environmental Quality | Subsequent Event
Long-term Purchase Commitment [Line Items]
Litigation settlement, amount due to third-party	1,500,000
Desoto County Regional Utility Authority | Subsequent Event
Long-term Purchase Commitment [Line Items]
Litigation settlement, amount due to third-party	$ 500,000

Debt - Summary of Debt (Detail)

Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt	$ 15,430
Total debt	15,430	$ 15,430
Debt, current	1,470	1,470
Debt, non-current	$ 13,960	13,960
Term loan
Debt Instrument [Line Items]
Interest Rate	0%
Long-term debt	$ 15,430	$ 15,430

Debt - Schedule of Estimated Pr

Debt - Schedule of Estimated Principal Payments on all Debt Outstanding (Detail) $ in Thousands	Mar. 31, 2022 USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]
2022 (remaining nine months)	$ 1,470
2023	1,470
2024	1,470
2025	1,470
2026	1,470
Thereafter	8,080
Total	$ 15,430

Debt - Additional Information (

Debt - Additional Information (Detail)			1 Months Ended			3 Months Ended
	Mar. 08, 2021 USD ($)	Oct. 22, 2020 USD ($)	Dec. 31, 2020 USD ($) draw note	May 31, 2020 USD ($)	Oct. 31, 2019 USD ($)	Mar. 31, 2022 USD ($) day	Mar. 31, 2021 USD ($)	Jan. 03, 2020 USD ($)	Nov. 22, 2010 USD ($) day
Number of days audited financials are to be delivered to lender | day						210
Long-term debt						$ 15,430,000
Repayment of long term line of credit						0	$ 257,454,000
Loss on extinguishment of debt						$ 0	$ 10,018,000
London Interbank Offered Rate (LIBOR)
Variable interest rate						9.05%
Line of Credit
Long-term debt								$ 250,000,000
Term loan | Mississippi
Debt Instrument face amount									$ 40,000,000
Number of semi-annual installments | day									24
Amended and restated term loan
Debt instrument semi annual payments		$ 700,000
Revolving debt facility
Line of credit facility maximum borrowing capacity					$ 200,000,000
Proceeds from line of credit				$ 100,000,000	$ 150,000,000
Repayment of long term line of credit	$ 276,800,000
Repayment of interest due on the notes	26,800,000
Loss on extinguishment of debt	$ 10,000,000
Amended revolving debt facility
Debt Instrument face amount			$ 37,500,000
Amended revolving debt facility | 13 Weekly Draw
Number of draws | draw			13
Proceeds from previous weekly draw			$ 2,900,000
Amended revolving debt facility | 4 Weekly Draw
Number of notes | note			4
Proceeds from previous weekly draw			$ 9,400,000
Minimum | Revolving debt facility
Maturity dates					8 days
Maximum | Revolving debt facility
Maturity dates					364 days

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Mar. 12, 2021	Mar. 08, 2021	Mar. 07, 2021
Stockholders' Equity Note [Abstract]
Common stock, shares authorized (in shares)	600,000,000	600,000,000	600,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)	219,222,346	219,195,971
Common stock, shares outstanding (in shares)	219,222,346	219,195,971		217,076,712	76,565,107
Preferred stock, shares authorized (in shares)			1,000,000
Preferred stock, par value (in dollars per share)			$ 0.0001
Preferred stock, shares issued (in shares)	0
Preferred stock, shares outstanding (in shares)	0

Stock Warrants - Additional Inf

Stock Warrants - Additional Information (Detail) - $ / shares		3 Months Ended
	Dec. 01, 2021	Mar. 31, 2022	Mar. 07, 2021
Class of warrants or rights number of securities called by each warrant or right (in shares)			1
Length of trading period used to determine reference value		30 days
Class of warrant or right exercised (in shares)		0
Private Warrants
Class of warrants or rights maturity (in shares)			366,666
Terminating initial public offering term		5 years
Public Warrants
Class of warrants or rights maturity (in shares)			16,666,637
Class of warrants or rights exercise price of warrants or rights (in dollars per share)		$ 11.50
Terminating initial public offering term		5 years
Class of warrant or right period of redemption of outstanding warrants with prior written notice of redemption		30 days
Number of trading days within trading period		20 days
Redemption price (in dollars per share)		$ 0.01
Minimum share price for warrant redemption (in dollars per share)		$ 18
Public and Private Warrant
Class of warrants or rights exercise price of warrants or rights (in dollars per share)			$ 11.50
Common stock | WorxWell
Warrants issued in connection with acquisition (in shares)	1,000,000

Stock Warrants - Summary of Out

Stock Warrants - Summary of Outstanding Common Stock Warrants (Detail) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	21,311,920	21,311,920
August 2010 - June 2011 | Common stock (previously Series B redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	46,498	46,498
Exercise price per warrant (in dollars per share)	$ 15.49
August 2011 - January 2012 | Common stock (previously Series C redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	53,256	53,256
Exercise price per warrant (in dollars per share)	$ 18.78
August 2012 | Common stock (previously Series D redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	45,388	45,388
Exercise price per warrant (in dollars per share)	$ 21.60
December 2013 | Common stock (previously Series E redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	63,296	63,296
Exercise price per warrant (in dollars per share)	$ 25.91
April 2015 - April 2016 | Common stock (previously Series F redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	45,207	45,207
Exercise price per warrant (in dollars per share)	$ 38.71
April 2016 - November 2018 | Common stock (previously Series H redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	1,135,391	1,135,391
Exercise price per warrant (in dollars per share)	$ 18.93
March 2017 | Common stock (previously Series H redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	1,849,431	1,849,431
Exercise price per warrant (in dollars per share)	$ 12.91
March 2014 | Common stock
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	2,324	2,324
Exercise price per warrant (in dollars per share)	$ 9.47
August 2015 | Common stock
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	12,916	12,916
Exercise price per warrant (in dollars per share)	$ 11.62
December 2018 | Common stock
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	24,910	24,910
Exercise price per warrant (in dollars per share)	$ 9.04
August 2020 | Private Warrants
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	366,666	366,666
Exercise price per warrant (in dollars per share)	$ 11.50
August 2020 | Public Warrants
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	16,666,637	16,666,637
Exercise price per warrant (in dollars per share)	$ 11.50
December 2021 | Common stock
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	1,000,000	1,000,000
Exercise price per warrant (in dollars per share)	$ 10

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)		3 Months Ended		12 Months Ended
	Mar. 08, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares)		25,902,000		27,582,000
Share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value (in dollars per share)			$ 4.38
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value			$ 6,400,000
Intrinsic value of options exercised			$ 400,000
Unrecognized compensation cost related to unvested stock options		$ 24,100,000
Compensation cost related to unvested stock options expected to be recognised over a weighted average service period		1 year 8 months 12 days
Options granted (in shares)		0
Weighted-average exercise price (in dollars per share)		$ 9.44		$ 9.43
Weighted-average remaining contractual term		6 years 8 months 12 days		7 years
Aggregate Intrinsic Value		$ 0
2018 Plan
Share based payment arrangement number of options available to purchase (in shares)	0
Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares)	24,657,302
Share-based compensation arrangement by share-based payment award, expiration period	10 years
2018 Plan | Minimum
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	20%
2018 Plan | Maximum
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	25%
2018 Plan | Year One Vesting
Share based compensation arrangement by share based payment award vesting period	1 year
2018 Plan | Year One Vesting | Officer Options
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	25%
Share based compensation arrangement by share based payment award vesting period	12 months
2018 Plan | Monthly Vesting | Minimum
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	1.67%
2018 Plan | Monthly Vesting | Maximum
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	2.08%
2021 Plan
Share based payment arrangement number of options available to purchase (in shares)	58,631,907
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)		21,086,366
2021 Plan | Officer Restricted Stock Units
Share based compensation arrangement by share based payment award vesting period	4 years
Share based compensation by share based payment arrangement equity instruments other than granted during the period (in shares)	12,500,000
2021 Plan | Officer Restricted Stock Units | Share Price Hurdle Achieved One
Share based compensation arrangement by share based payment award percentage of non option equity instruments granted	50%
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)	$ 15
2021 Plan | Officer Restricted Stock Units | Share Price Hurdle Achieved Two
Share based compensation arrangement by share based payment award percentage of non option equity instruments granted	50%
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)	$ 20
2021 Plan | Officer Options
Share based compensation arrangement by share based payment award vesting period	4 years
2021 Plan | Officer Options | Class A common stock, par value, $0.0001 per share
Share based payment arrangement number of options available to purchase (in shares)	5,000,000
2021 Plan | Unvested restricted stock units
Share based compensation by share based payment arrangement equity instruments other than granted during the period (in shares)		0
2021 Plan | Year One Vesting | Officer Options
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	25%
Share based compensation arrangement by share based payment award vesting period	12 months
2021 Plan | Monthly Vesting | Officer Restricted Stock Units
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	75%
Share based compensation arrangement by share based payment award vesting period	36 months
2021 Plan | Monthly Vesting | Officer Options
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	75%
Share based compensation arrangement by share based payment award vesting period	36 months
CEO Incentive Plan
Share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value (in dollars per share)			$ 3.54
Unrecognized compensation cost related to unvested stock options		$ 68,500,000
Options granted (in shares)		25,000,000
Weighted-average exercise price (in dollars per share)		$ 10
Weighted-average remaining contractual term		8 years 10 months 24 days
Aggregate Intrinsic Value		$ 0
Share based compensation by share based payment award options shares issued in period		0
Compensation cost related to options expected to be recognised over a weighted average service period		4 years 2 months 12 days
CEO Incentive Plan | Common Stock
Share based compensation arrangement option granted to purchase stock at exercise price (in dollars per share)	$ 10
CEO Incentive Plan | Unvested restricted stock units
Grant date fair value of RSUs vested		$ 200,000
Unrecognized compensation cost related to Equity instruments other than options		$ 30,800,000
Compensation cost related to equity instruments other than options expected to be recognised over a weighted average service period		1 year 7 months 6 days

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Options Exercisable under CEO Incentive Plan (Detail)	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Option Shares	0
CEO Incentive Plan | Year One Vesting
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 20
CEO Incentive Plan | Monthly Vesting
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 30
CEO Incentive Plan | Share-based Payment Arrangement, Tranche Three
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 40
CEO Incentive Plan | Share-based Payment Arrangement Tranche Four
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 50
CEO Incentive Plan | Share-based Payment Arrangement Tranche Five
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 60
CEO Incentive Plan | Share-based Payment Arrangement Tranche Six
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 70
CEO Incentive Plan | Share-based Payment Arrangement Tranche Seven
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 80
CEO Incentive Plan | Share-based Payment Arrangement Tranche Eight
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 90
CEO Incentive Plan | Share-based Payment Arrangement Tranche Nine
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 100
CEO Incentive Plan | Share-based Payment Arrangement Tranche Ten
Option Shares	2,500,000
Average Trading Price per Share of the Combined Entity (in dollars per share) | $ / shares	$ 110

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of Share-based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Number of Shares Subject to Stock Options Outstanding
Beginning balance (in shares)	27,582
Options granted (in shares)	0
Exercised (in shares)	0
Canceled/forfeited (in shares)	(1,680)
Ending balance (in shares)	25,902	27,582
Options vested and expected to vest (in shares)	19,937
Exercisable (in shares)	25,670
Weighted- Average Exercise Price
Weighted-Average Exercise Price, Beginning balance (in dollars per share)	$ 9.43
Options granted (in dollars per share)	0
Exercised (in dollars per share)	0
Canceled/forfeited (in dollars per share)	9.37
Weighted-Average Exercise Price, Ending balance (in dollars per share)	9.44	$ 9.43
Weighted-Average Exercise Price, Options vested and expected to vest (in dollars per share)	9.44
Weighted-Average Exercise Price, (in dollars per share)	$ 9.44
Weighted-Average Remaining Contractual Term, Outstanding	6 years 8 months 12 days	7 years
Weighted-Average Remaining Contractual Term, Options vested and expected to vest	6 years 4 months 24 days
Weighted-Average Remaining Contractual Term, Exercisable	6 years 8 months 12 days
Aggregate Intrinsic Value, Beginning balance	$ 0
Aggregate Intrinsic Value, Ending balance	0	$ 0
Aggregate Intrinsic Value, Options vested and expected to vest	0
Aggregate Intrinsic Value	$ 0
Share price (in dollars per share)	$ 1.84
Pro Forma
Weighted- Average Exercise Price
Share price (in dollars per share)		$ 3.91

Stock Based Compensation - Summ

Stock Based Compensation - Summary of Outstanding Restricted Stock Units (Detail) - 2021 Plan - Unvested restricted stock units shares in Thousands	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Number of Shares
Beginning balance (in shares) | shares	11,643
Granted (in shares) | shares	0
Vested (in shares) | shares	(26)
Canceled (in shares) | shares	(811)
Ending balance (in shares) | shares	10,806
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 6.14
Granted (in dollars per share) | $ / shares	0
Vested (in dollars per share) | $ / shares	7.58
Canceled (in dollars per share) | $ / shares	6.28
Ending balance (in dollars per share) | $ / shares	$ 6.13

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail) - $ / shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share price (in dollars per share)	$ 1.84
Share-based Payment Arrangement, Option | CEO Option Award
Expected volatility	54%
Expected terms (in years)	10 years
Expected dividends	0%
Risk-free rate	1.59%
Share price (in dollars per share)	$ 9.19
Discount for lack of marketability	20%
Share-based Payment Arrangement, Option | Officer
Expected volatility	53%
Expected terms (in years)	6 years
Expected dividends	0%
Risk-free rate	1.07%
Share price (in dollars per share)	$ 9.19
Unvested restricted stock units | Officer
Expected volatility	56%
Expected terms (in years)	4 years
Expected dividends	0%
Risk-free rate	0.60%
Share price (in dollars per share)	$ 9.19
Share-based Payment Arrangement, Employee
Expected volatility		53%
Expected terms (in years)		6 years
Expected dividends		0%
Risk-free rate		1.07%

Stock-Based Compensation - Su_4

Stock-Based Compensation - Summary of Stock-based Compensation (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based compensation expense	$ 17,468	$ 10,463
Cost of revenue
Share-based compensation expense	363	879
Research and development
Share-based compensation expense	69	914
Selling, general, and administrative
Share-based compensation expense	$ 17,036	$ 8,670

Income Taxes (Detail)

Income Taxes (Detail)	3 Months Ended
	Mar. 31, 2022 USD ($)
Income Tax Disclosure [Abstract]
Changes in estimated uncertain tax benefits	$ 0

Net Loss Per Share - Summary of

Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Net loss	$ (82,372)	$ (74,035)
Weighted-average shares outstanding, basic (in shares)	214,232,210	55,500,398
Weighted-average shares outstanding, diluted (in shares)	214,232,210	55,500,398
Net loss per share, basic (in shares)	$ (0.38)	$ (1.33)
Net loss per share, diluted (in shares)	$ (0.38)	$ (1.33)

Net Loss Per Share - Summary _2

Net Loss Per Share - Summary of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	47,219,198	50,058,206
Stock options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	25,901,653	29,630,036
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	5,625	0
Warrants to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	21,311,920	20,428,170

Net Loss Per Share - Additional

Net Loss Per Share - Additional Information (Detail) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 08, 2021
Earn out shares subject to vesting and potential forfeiture	4,970,000		4,970,000
Options granted (in shares)	0
Non Qualified Stock Option Awards | CEO Option Award
Options granted (in shares)	25,000,000
Unvested restricted stock units | Officer
Share based compensation by share based payment arrangement equity instruments other than granted during the period (in shares)	10,800,000	12,500,000